ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001438.1|Warkmycin_1 # 2 # 1789 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.695	BGC0001438.1|Warkmycin_1 	2	1789	-	Loose	620	30.8018	ROB-5	26.47	3005075	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGATCGTTCTTGGATACAACGGCTTCTCGCGGGTGGCGGAACTCTTCGGCCGGCTGTACGGCCACACCCCCGAGAGCGTCGATCGGCACAACCTCATCGGCCACGACGCCGCGGCCTGCCTCTTCGTCGACGGCCGGCTGGTGGCCGCGGTGGAGGAGGAGCGCCTCAACCGGCAGAAGAAGACCAGCGCCTTCCCGGCGCTGGCCATCCGCTGGTGCCTCGACCAGGCCGGTCTCGACTTCGACGACGTGGACCGGTTCGCCTTCGGCTGGAACCACGACGAGGAGTACGCGGACGCCGTGGTGACCGGTGTCGCCGGCTCCCCGGAACCGGCCGAGGCCCGGCTCCGGACCCTCACCACCTTCGGCGAGCTCTACCTGGGGGCGATCGGCCGCAGCGCGCTGGTGGAGGACTTCACCCGGTCCACCGGCTACGCCCTGCCGGACGCCAAACTCGTCACCGTGCCGCACCACCACGCCCACCTGGCGTGCGGCCGGCTGTTCTCGGGGGCCGCGGACGCCGCGTTCCTCGTGAACGACGGCACGGCCGAACGGAACAGCGCCATCATGGGCGAGGTCCGGAACGGCAAGGTCGAGGTGTTCGACCGGTTCACCATCGACGCCGGCCATTCGATCGCCCAGCTCTTCGGCGCGATCACCCGCTACCTGGGATTCGTCCCCAACAACGACGAGTACAAGGTGATGGGGCTGGCCGGATTCGGCGTGGCGCCCGAGAAGAACCCCCTGCTCGGTGAGGTCGTCACCCTGGAGGAGGGCGGCCGCTACAGCCTGCGTCTGGCCCACGACCGGCGTGGACCACGCGCCTACGACGGCCTGCTCGACGAGCTGTTCGGCGGCGACGACGCCACGCGCCACACCTTCGACCACCGGGTGCGGCTGGCCTGCGCGGCCCAGCAGATGATCGAGACGGTCACCGCCCACCAGCTGCGGGCGCTCGCCGGGGCGACCGACCTGCGGGACCTGATCTTCGAGGGGGGCCTGGCGCTCAACTGCGTCAACAACACCAAGCTCCTGGAGGAGACGCCGTTCGAGCGGATGGAGGTGAGCTTCGGAGCGAGTGACCCCGGCGTCTCGATCGGCGCCGCCGCACACGTCGCGTTCGAGCAGGCCGAACCCGTCACCGCCGCGATGGCGCCCTACACCGGCCCCGCGTACGGGGCCGACGAGATCAGGAAGGTCCTCCGGCGGCACGAACCGGCACTCGTCTGGGAGGAGATACCGACCGCCGAGGTGGCCCGCAGGACCACGGACCTGCTGTCCGCCAAGAAGGTCGTCGGCTGGTTCCAGGGCCGCACGGAATTCGGGCCCCGGGCGCTCGGCAACCGCAGCATCCTCGCCGACCCCAGCCACGCCGACATGAAGGACGTCATCAACAACCGGGTCAAGCACCGGGAGCCGTTCCGGCCCTTCGCCCCGATCGTGCTGGAACGGGACGCCGCGAAGGTCTTCGAGCTGGGCAAGAAGGACCGGTCCCCGTACATGACCTTCGTCTTCCCGGTCCGCCCGGAGTACACCGAGAAGATCGCGGCGGCCACCCACGTGGACGCCACCTCCCGCATCCAGACCGTCACGGAGGAGGGCAATCCGCTCCTGGCGGAGCTGCTGAAGGAGTTCACCGCGCGGACCGGGGTGCCGTGTCTGGTGAACACGTCCTTCAACGTGGCGGGTGAGCCGATCGTCTGCTCACCCGAGGACGCCGTCGCGTGCTTCCTCGGCACGGACATCGATCACCTGGTCATCGGGGACTTCGTGGTCTCCAAGAACTGA	MIVLGYNGFSRVAELFGRLYGHTPESVDRHNLIGHDAAACLFVDGRLVAAVEEERLNRQKKTSAFPALAIRWCLDQAGLDFDDVDRFAFGWNHDEEYADAVVTGVAGSPEPAEARLRTLTTFGELYLGAIGRSALVEDFTRSTGYALPDAKLVTVPHHHAHLACGRLFSGAADAAFLVNDGTAERNSAIMGEVRNGKVEVFDRFTIDAGHSIAQLFGAITRYLGFVPNNDEYKVMGLAGFGVAPEKNPLLGEVVTLEEGGRYSLRLAHDRRGPRAYDGLLDELFGGDDATRHTFDHRVRLACAAQQMIETVTAHQLRALAGATDLRDLIFEGGLALNCVNNTKLLEETPFERMEVSFGASDPGVSIGAAAHVAFEQAEPVTAAMAPYTGPAYGADEIRKVLRRHEPALVWEEIPTAEVARRTTDLLSAKKVVGWFQGRTEFGPRALGNRSILADPSHADMKDVINNRVKHREPFRPFAPIVLERDAAKVFELGKKDRSPYMTFVFPVRPEYTEKIAAATHVDATSRIQTVTEEGNPLLAELLKEFTARTGVPCLVNTSFNVAGEPIVCSPEDAVACFLGTDIDHLVIGDFVVSKN	MFNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNTATNLLLKELGGVEQYQRILRQLGDNVTHANRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	195.08	gnl|BL_ORD_ID|2794|hsp_num:0	3811			231	519	
BGC0001438.1|Warkmycin_2 # 1812 # 3041 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAGA;rbs_spacer=4bp;gc_cont=0.692	BGC0001438.1|Warkmycin_2 	1812	3041	-	Loose	1750	28.4906	amrB	32.43	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCATTGAGGAGTGCCGCGCCTGCGGCAACAGCGAACTGCTTCCGGTGCTGGACCTGGGCCCGCAGGCGCTGACCGGGGTCTTCCCGCGGAGCCGGGACGAGGACGTGCCCCAGGTCCCCCTCGACCTGGTGCGGTGCTCACCCGGCGGCTGCGGCCTGGTGCAACTGCGCCACACGGCCGACCTGTCGCTCATGTACGGCGAGGGGTACGGATACCGCTCCGGGATCCGCGAGTTCATGCGCAACCACCTGCACGGCAAGGTCGCCGACCTCACCGCCCTGATGCAGCCGGGCCCCGGGGACCTGATCGTCGACATCGGGAGCAACGACGCCACGCTGCTGCGCGGCTACGCGGAGGGCCCGACCCTCGTCGGCGTCGACCCGACCGGGGAGAAGTTCCGCTCGCACTACCCGCCGGGCGCCGAGCTGCTGCCCGACTTCTTCTCGCGCAAGCTCGTCGAGGAACGGTTCGGCTCCCGCCGCGCCAAGATCGTCACTTCCGTGGCGATGTTCTACGACCTGCCGCGCCCCCTGGAGTTCATGCAGGACGTGCACGACATCCTGGACGAGGACGGCGTCTGGCTGATGGAGCAGAGCTACCTCCCGGCGATGCTCCAGGCGGCGGCGTACGACGTGATCTGCCACGAACACCTGGAGTACTACGCCCTCCAGCAGATCGAGTGGATGGCGGAGCGCGTCGGACTGCGGGCCATCAGGGCCGAGCTCACCGACGTGTACGGCGGCAGCCTCTGCGTCGTGCTGGCCAAACGGTCCAGCCGGCACCGGGTGGACGAGGCCGGCCTCGCCCGCATCAGGGCCCACGAGGCAGCCCTCGGACTGGGCACGGCGGCCCCCTTCGAAGCCTTCGCCACCCGTTCGCTCACCTCGCGTGACCAGCTGCGGGACTTCCTGGACCGCTCCCGCCGAGAGGGCCTCACCACCCTGGGCTACGGGGCCTCCACCAAGGGCAACGTCATCCTCCAGTTCTGCGGACTCACCGAGGCGGACCTGCCGTGCATCGGCGAGGTCAGCCCGGAGAAGTGGGGCGGCTTCACACCCGGCACCGCGATTCCGATCGTCTCCGAGGAGGAGGCCAAGGCCCACCGGCCCGATCAACTGCTGGTGCTGCCCTGGATCTACCGCGAGGGATTCATCGAGCGGGAACAGGAGTTCACCGAGAACGGCGGCAAGCTGGTGTTCCCGCTGCCGGATCTGACCATCGTATGA	MIIEECRACGNSELLPVLDLGPQALTGVFPRSRDEDVPQVPLDLVRCSPGGCGLVQLRHTADLSLMYGEGYGYRSGIREFMRNHLHGKVADLTALMQPGPGDLIVDIGSNDATLLRGYAEGPTLVGVDPTGEKFRSHYPPGAELLPDFFSRKLVEERFGSRRAKIVTSVAMFYDLPRPLEFMQDVHDILDEDGVWLMEQSYLPAMLQAAAYDVICHEHLEYYALQQIEWMAERVGLRAIRAELTDVYGGSLCVVLAKRSSRHRVDEAGLARIRAHEAALGLGTAAPFEAFATRSLTSRDQLRDFLDRSRREGLTTLGYGASTKGNVILQFCGLTEADLPCIGEVSPEKWGGFTPGTAIPIVSEEEAKAHRPDQLLVLPWIYREGFIEREQEFTENGGKLVFPLPDLTIV	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	39.21	gnl|BL_ORD_ID|428|hsp_num:0	476			2145	2256	
BGC0001438.1|Warkmycin_3 # 3103 # 3879 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAGAGA;rbs_spacer=7bp;gc_cont=0.685	BGC0001438.1|Warkmycin_3 	3103	3879	-	Loose	750	25.7942	mdtH	40.0	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGACATCGAGTACAAGGACCCGCGCACCGTGCCGCACGAGTCGCAGGGGGAGCGCGACTCACGGTTGCGGCTGACCGAACTGCTGGCCAGGACCCCGATCCCGCCCGAATACCTGATCGACAACCTGCCCGTCTATCTGCGCCGCCCCCAGCTGGCGGACCTGCTGGCCATGGACGCGCTGTACCGGCGCATCGTCGACGTGCCGGGCGTCATCATGGAGTTCGGCGTGCTGCACGGACGGCACCTGGCCGCCTTCACCGCACTGCGCAGCATCTACGAGCCCTACAACTCGCTGCGCCGCGTCATCGGGTTCGACACCTTCACCGGCTTCCCGGACGTCTCCGAGATCGACCGGGCCACCCCCAGCGCGGTCGCCGGCCGGTTCGCCGTCCCCGAGGACGAGGTCGACCACCTGCGCCAGGTGCTGGCGGCCCACGAGGCGAACGAACCGTACGGCCACACCCAGCGCAGCTTCGTCGTCCAGGGCGACGTACGCAAGACGGTCCCGCAGTACCTCCAGGAGAACCCCGAGACGGTCGTCGCGCTCGCCTACATCGACCTCGACCTGTACGAACCGACCCTGGAGACGCTGCACGCGCTGCGCCCGCACCTGGCCAAGGGCAGCATCATCGCCTTCGACGAGCTGGCCCACCCCAAGTGGCCGGGCGAGACCAAGGCGCTGACCGAGTTCCTGGACCTGGGCAGCGTCAAACTCCATCAGCTGCCCCACCGCGAGTCCCCGATCATCTACCTGGTGTGGGGCGAGAACTGA	MTDIEYKDPRTVPHESQGERDSRLRLTELLARTPIPPEYLIDNLPVYLRRPQLADLLAMDALYRRIVDVPGVIMEFGVLHGRHLAAFTALRSIYEPYNSLRRVIGFDTFTGFPDVSEIDRATPSAVAGRFAVPEDEVDHLRQVLAAHEANEPYGHTQRSFVVQGDVRKTVPQYLQENPETVVALAYIDLDLYEPTLETLHALRPHLAKGSIIAFDELAHPKWPGETKALTEFLDLGSVKLHQLPHRESPIIYLVWGEN	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	64.18	gnl|BL_ORD_ID|342|hsp_num:0	375			903	1023	enoxacin; norfloxacin
BGC0001438.1|Warkmycin_4 # 3919 # 4947 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.754	BGC0001438.1|Warkmycin_4 	3919	4947	-	Loose	650	29.261	clcD	30.51	3004599	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGCAGAACCCTTCGCCACGCACACCGGTGCCGGACCCCGATGACCGGGCCGCGGCCGAAGTGACCGGCGACGCCCCCACCGTCGTCGTCCTGGGCGGCACCGGATGCATCGGGCGGCACATCTGCGCCGCCTTCGCCGACCAGGGGTACCGGGTCGTCACGGTGGCGCGCCGCCCCGCCCCCCGGGTGACGCCCCACCCGCACCGCACGCTCGACCTCCAGACGGCCGGGCCGCCCGTGCTGCGCGCGCTGTTCGACGACGAACGCGCCGATGTCGTCGTCAACGCCACCGACATGGCGGGCGCGACCGATACGACCGGCGTCGCCGACGGCGGCGAGGCACGCGCCGCCGAACTGCTCGACGCCAACGAGGGGCTCTCCCGCAGACTCGTCGACGCCCTGTCGGGCGCGGCGCGCGCACCCCGGCTCGTCCACATCGGGACCATCCACGAGTACGGTCCCGGCGACAGCGGCGTCCCGCTGCGCGAGGACGTCGAGCCCGCTCCCGTCAACGCCTACGCACGGGCGAAACTGGCCGGCTCCCGGGCCGTCCTGGACGCGGCACGCTCGGGAGCCGTGAGCGCGGTGGTGCTCCGGCTCGTCAACACCTGCGGGCCGTATCCCACACCGGCCGGGTTCGCCGGGAAGCTCCTGCCCACCCTGCGCGCCGCCGCTGCCGCCGGTGAGGCGCCGGAGATCACCGTGGGCGCTGCGATGCGCGACTGGATCGACGTCCGGGACATCGCCGGGGCCGCGGTCCTCGCGGCGCGGCGGCCGGTGAGCGGGCACGCCTTCAACATCGGCAGTGGCGTCTGCGTGTCCATGCGGGAGCTGGTCGGACACGCCCTGGCGGCGGCCGGCCTGCCCGACTCGGGAGTCCGCGAATCCACCGGGCAGCTGCGCAGCCTCGGCGCCGACTGGATCCAGGCCGACATCGGCCGGGCCCGCGCACTGCTCGGCTGGAGCCCCCTCGTCCCGCTGAAGCAGTCGCTGCGCGACATGTGGGACGCGGGGGAGACCAGCCGCTGA	MQNPSPRTPVPDPDDRAAAEVTGDAPTVVVLGGTGCIGRHICAAFADQGYRVVTVARRPAPRVTPHPHRTLDLQTAGPPVLRALFDDERADVVVNATDMAGATDTTGVADGGEARAAELLDANEGLSRRLVDALSGAARAPRLVHIGTIHEYGPGDSGVPLREDVEPAPVNAYARAKLAGSRAVLDAARSGAVSAVVLRLVNTCGPYPTPAGFAGKLLPTLRAAAAAGEAPEITVGAAMRDWIDVRDIAGAAVLAARRPVSGHAFNIGSGVCVSMRELVGHALAAAGLPDSGVRESTGQLRSLGADWIQADIGRARALLGWSPLVPLKQSLRDMWDAGETSR	MQQKNKYIRIQEFLKQNKFPNYRMKQITNAIFPGRINNFNEITVLPKSLRDMLIEEFGESILNIVPLKAQQSTQVSKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKRNLTSDEITDQILYFHLQGHSIDSISFMGMGEALANVQVFDALNVLTDPALFALSPRRLSISTIGIIPNIKKLTQNYPQVNLTFSLHSPFNEQRSELMPINERYPLSDVMDTLDEHIRVTSKKVYIAYIMLHGVNDSIEHAKEVVNLLRGRYRSGNLYHVNIIRYNPTISSRMRFEEANEKCLVNFYKELKSAGIKVTIRSQFGIDIDAACGQLYGNYQKTNSQ	97.99	gnl|BL_ORD_ID|2733|hsp_num:0	3300			798	972	clindamycin; linezolid; florfenicol; quinupristin; tiamulin; dalfopristin; quinupristin-dalfopristin
BGC0001438.1|Warkmycin_5 # 4904 # 5833 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.662	BGC0001438.1|Warkmycin_5 	4904	5833	-	Loose	1800	28.8758	mdtC	36.84	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGGGAATCATTCTCGCCGGCGGCAGCGGAACGCGACTCAAACCGCTGACCGGGGTGGTCTCCAAGCAGATTCTCCCCGTCTACAACAAGCCGATGATCTACTATCCGCTCTCGGTGCTCATGCTCGCCGGAATCCGCGACATTCTGCTGATCTCCGCACCGGGTCACCTGGATATGTTCCGCCGGCTCCTCGGTGACGGATCGAGCCTCGGCGTGCGCATCGACTACGCCGAGCAGAAAGAACCCAACGGCATCGCCGAGGCGTTCCTGCTGGGCGCCGACCACATAGGGGACGACCAGGTCGCCCTCATCCTCGGCGACAACGTCTTCCACGGGTACAAGTTCTCCGACCTGCTGCGCAGGACCGTGGAGCAACTGGACGGCTGCGCGCTGTTCGGCTACCCCGTGCAGGACCCCTGGCGGTACGGCATCGCCGAACTGGACGCCGACCGCCGGCTCGTGGGCCTGGCGGAGAAGCCGGGCGAACCCCGCTCCAACATCGCGGTCACCGGCCTCTACATGTACGACAACGACGTCGTCCGGATGGCCCAGGACCTGGTGCCCTCCGAGCGCGGCGAGCTGGAGATCACGGACATCAACCGGATCTACCTGGAACAGGGCAGGGCGCATCTGGCCGAGCTCGGACGGGGCTTCGTCTGGCTCGACATGGGCACCCACGACTCCCTCCTGGAGGCCGGTCAGTACGTACAGATCCTCGAACAGCGCCAGGGGGTCCGGATCGGCTGTGTCGAGGAGGTGGCGTACCGCAAGGGCTTCATCGACGCCGAGGAATGCCGGCTGCTGGCCCACGAACAGGCCGGCGAGTACGGGGAGTACCTCCTCGACCTCATCGGCGCGGACCGCGTCCCGTCCCGGAGGAACCATGCAGAACCCTTCGCCACGCACACCGGTGCCGGACCCCGATGA	MKGIILAGGSGTRLKPLTGVVSKQILPVYNKPMIYYPLSVLMLAGIRDILLISAPGHLDMFRRLLGDGSSLGVRIDYAEQKEPNGIAEAFLLGADHIGDDQVALILGDNVFHGYKFSDLLRRTVEQLDGCALFGYPVQDPWRYGIAELDADRRLVGLAEKPGEPRSNIAVTGLYMYDNDVVRMAQDLVPSERGELEITDINRIYLEQGRAHLAELGRGFVWLDMGTHDSLLEAGQYVQILEQRQGVRIGCVEEVAYRKGFIDAEECRLLAHEQAGEYGEYLLDLIGADRVPSRRNHAEPFATHTGAGPR	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	30.15	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2901	3015	novobiocin
BGC0001438.1|Warkmycin_6 # 5830 # 6465 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.695	BGC0001438.1|Warkmycin_6 	5830	6465	-	Loose	600	26.5646	APH(9)-Ia	23.58	3002662	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	ATGAAAGCGCGAAAGCTCGCTGTGGAAGGCGCCATAGAATTCACCCCGCGGGCGTTCTCCGACGACCGCGGGGTGTTCGCCACCCCATTCCAGCAGTCTGTATTCGAGACAGCGAACGGCGCACCGTTCTTCCCGGTCGCCCAGAGCAATCACAGCGTGTCCCGGCGCGGAGTCGTCCGGGGCATCCACTACACCGGGGCGCCCCCCGGCGCCGCCAAGTACGTGTACTGCGCCAGCGGCCGATCGCTCGACATCGTCGTGGACATCAGGACCGGCTCGCCCACCTACGGGCGCTGGGACGCGGTCCTCATGGACCCGGAGGAACTCCGCGCCGTCTACCTGCCGGTGGGCGTCGGGCACGCGTTCGTCGCGCTCACCGACCACACGGTGATGTCGTACCTCACCTCGACGCCGTACGTGGCGGACAACGAGCTGGCGCTGTCGCCCCTCGACCCGGCCCTCGGCCTGCCGATCCCCGAGGACATCGAGCCGTTGCTCTCCGAGCGCGACACCCGTGCCCTCACCCTCGAAGAGGCGGCCGGACGCGGTCTGCTGCCGTCCTACGAGCAGAGCCTGAAACTGGAGGCCGCGCTGAGCGCCGGTGCGGAGCCGAGGGCGACGGGACGTACGGCATGA	MKARKLAVEGAIEFTPRAFSDDRGVFATPFQQSVFETANGAPFFPVAQSNHSVSRRGVVRGIHYTGAPPGAAKYVYCASGRSLDIVVDIRTGSPTYGRWDAVLMDPEELRAVYLPVGVGHAFVALTDHTVMSYLTSTPYVADNELALSPLDPALGLPIPEDIEPLLSERDTRALTLEEAAGRGLLPSYEQSLKLEAALSAGAEPRATGRTA	MLKQPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIGGGVGNVWNKPHEIQYFYEGYGEINVDKTILSYYRHERIVEDIAVYGQDLLSRNQNNQSRLESFKYFKEMFDPNNVVEIAFATEQ	63.75	gnl|BL_ORD_ID|227|hsp_num:0	252			474	762	spectinomycin
BGC0001438.1|Warkmycin_7 # 6651 # 7808 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GAGAG;rbs_spacer=4bp;gc_cont=0.738	BGC0001438.1|Warkmycin_7 	6651	7808	-	Loose	700	51.6026	mgtA	25.42	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGCGCGTACTCTTCGTCACCGGTGGAGGGCAGGCCACCGTCTTCGCCCTGGCCCCGCTCGCCACCGCCGTGCGTGCCGCCGGACACCAGGTGTTCATGGCCGCCAACCACGAGGTCATGCCTGCGATCACCGCGTCGGCGCTGCCCGCGGTGCCGGTCACCGAAAGCCCGTTGCGGCACTTCATCTCGCACGACCGGCAGGGGCGGCCGGTCGATCTGCCGCTCGGCAGGCCGGTCGCCGAACAGGCCGAGTTCACCGGCCGTTGGTTCGGCAGAATGGCGGCGGAGAGTCTGCCGCTGCTGCGGGACTTCACGGCACGGTGGCGCCCGGACCTCGTCGTGGGCGGCACGAGCACCTACGCGGCCGCACTGCTGGCGCGCCATCTCGGCGTTCCGTACGTCCGGCTCGCCTGGGACGCGATAGACGCCCGCCGAGTGCACCCCGGCGCGAGCCGGGAACTCGCCCCCGAACTGGCCCTGCTGGGGCTGGACGAGCTTCCCGCGCCCGATCTGTTCATCGACGTCTGCCCGCCCGGGCTGCGGTCCCGGGAGGCGGACCCCGCCGAACCGATGCGGTTCGTGCTGGGCAATCTGCACCGGGTGCTCGAACCCTGGATGTACACCCGGGGCGAGCACCGGCGGATCTGTGTCACCGCGGGCAGCCAGGTGACCCGGGCCGGCGGGCACGGGCTCTTCGCGTTCCTCACCAGGACGGTCCGGGAGCTCGCCCCGCTCGACGCCGAGGTGCTGGTCGCCGCTCCGCAGGCGCTGATCGACGACGTGCGGTCGGAGTGCCGGGACGTCGGCCGACTGCGGGTCGGCTGGATGCCGTTGGACGTGGTCGCGCCCACCTGCGACCTGCTCGTCCACCACGGCGGCGGAGTCACCAGCCTCACCGGTATGTGCGCCGGCGTCCCCCAGGTCGTGGTCCCCGGGGCCGACATGCTCGCCGACGCGGCCCGCCTGCTCGCCGCGTACGGTGCGGCGGTCACCCTGCCGACCGGTGACGACCGGCCGGGCGCCGTGGGCGAGGCCGCTCGCCAGGTGCTGTCGGACGGGGGTCACGCCGCGCGCGCCGGGGAGCTGCGGGCCGAGATCGAGGCCATGCCGACACCGCACGATCTGGTCGCCGTCCTGGAGAAGTTGGCCCGCGTCTGA	MRVLFVTGGGQATVFALAPLATAVRAAGHQVFMAANHEVMPAITASALPAVPVTESPLRHFISHDRQGRPVDLPLGRPVAEQAEFTGRWFGRMAAESLPLLRDFTARWRPDLVVGGTSTYAAALLARHLGVPYVRLAWDAIDARRVHPGASRELAPELALLGLDELPAPDLFIDVCPPGLRSREADPAEPMRFVLGNLHRVLEPWMYTRGEHRRICVTAGSQVTRAGGHGLFAFLTRTVRELAPLDAEVLVAAPQALIDDVRSECRDVGRLRVGWMPLDVVAPTCDLLVHHGGGVTSLTGMCAGVPQVVVPGADMLADAARLLAAYGAAVTLPTGDDRPGAVGEAARQVLSDGGHAARAGELRAEIEAMPTPHDLVAVLEKLARV	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	92.11	gnl|BL_ORD_ID|2293|hsp_num:0	515			309	1188	erythromycin; tylosin; azithromycin; methymycin
BGC0001438.1|Warkmycin_8 # 7899 # 9032 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAGAG;rbs_spacer=10bp;gc_cont=0.728	BGC0001438.1|Warkmycin_8 	7899	9032	-	Loose	700	34.6538	oleI	25.81	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGGCTGCTGTTCGTCACGGGACCCACCCCGTCCAACGTCTTCGCCCTCGCGCCGCTCGCCCTCGCGGCACGCGACGCGGGACACCAGGTCTTCATGTCGACCGTACGGGAGCGGACCTCCGTCGTGACCGGCGTCGGGCTTCCCGCGCTCGCCGCGACGACCACCCCGCTCGCCGACCTCAAGGCGACCCGGCGCTCCGGCGAACGCGAGCACGTCCCGGACGACGTGGACCATCCCGAGTTCATCCGGTACACCGGCCGCTGGTTCGGACGCGTGGCGGCCGAGAGCCTGGTCACGCTCCGCGAGGTCGCGGCGGCCTGGCGGCCGGACGTGGTGATCGGCGGCCCCCACGCCTACGCGGCGGCCCTGCTGGCCCACGAGCTGTCCGTGCCATGGGTACGGCACACCTGGACCGCCCTCGACACCCGGGGCATCCACATCGGCAGCGAGTCCGAGCTCGCGCCGGAACTGGGCCGGCTCGGCCTCGACCGGATACCGCCCCCGGCCATGCTCATCGACAACTGCCCGCCCTCGATCCGCCAGGCCGACGCCGCTCCCGCCCAGCAGATCCGCTACATCCCGGTCAACTCCCAGTGCACCACCGAACCCTGGATGTACACCCCCGGCGAGCGGCGCAGGGTCTGCGTCACGGGCGGCAGCATGGCCGCCCGCGACAACAACTTCGAGCTGATCCGCTCCATGGTGAGGCATCTGCGGGCGCTGGGGGCCGAGGTCGTCGTCCCCGCACCGCAGGAGACGGCCGACGCGCTCCGCGCGGAGTTCGGCGACATCAGGGCCGGCTGGTTCCCGCTGGACGTGGTGATGCCGACCTGCGCACTGGTCGCGCACCACGCGGGCGGTCTCACCGGGCTGACCGCCACGCTCTCCCACGTCCCCCAACTGCTGTTGCCGCAGGAGGCGAAGGTCCGGGAGTCCTCCCGGCTCGTGGGCGCGTACGGGTGCGGGATCAGCCTGCTGCCCGACGAGGCGACCGAGGACAGGGTCGCCGACGCGCTGGAGGAGTTGCTCCACAAGCCCTCCTACGCGGAGCGTGCGGGCGACCTCGCCCGGGAGGTCGACGGGATGCCGGCGCCGGTCGAGGTCCTCGACCTCGTGACCTCCCTGGCGTGA	MRLLFVTGPTPSNVFALAPLALAARDAGHQVFMSTVRERTSVVTGVGLPALAATTTPLADLKATRRSGEREHVPDDVDHPEFIRYTGRWFGRVAAESLVTLREVAAAWRPDVVIGGPHAYAAALLAHELSVPWVRHTWTALDTRGIHIGSESELAPELGRLGLDRIPPPAMLIDNCPPSIRQADAAPAQQIRYIPVNSQCTTEPWMYTPGERRRVCVTGGSMAARDNNFELIRSMVRHLRALGAEVVVPAPQETADALRAEFGDIRAGWFPLDVVMPTCALVAHHAGGLTGLTATLSHVPQLLLPQEAKVRESSRLVGAYGCGISLLPDEATEDRVADALEELLHKPSYAERAGDLAREVDGMPAPVEVLDLVTSLA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	88.92	gnl|BL_ORD_ID|1684|hsp_num:0	1824			933	1209	oleandomycin
BGC0001438.1|Warkmycin_10 # 10300 # 11505 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.751	BGC0001438.1|Warkmycin_10 	10300	11505	-	Loose	700	72.7886	oleD	28.18	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTCCTGGTGATGACCACTCCCGATCCGAGCCATCTGCCGCCCCTGGCACCGGTCGCCTGGGCGCTGCGCGCCGCGGGCCACGAAGTGCTGGTCGCCGGCCAGCCCGACAGCGCCGAGTCCGCCAGGACCACGGGGCTGAGCATGGTCGCGTTCGGCGAACCGTTCGACACCGAACAGTTGGTGCTGAACTCCCTGGCCCCCGGCAAGCGCCCGCTGGAGTGCCGCCCCGGCAGCGCCCCCGGCACCGCGCCCCCCGTCAAGGGTGGCTTCGGCGGCGTCTGGATCGAGCGGGCGCGGGCCATGGCGGGGGAGTACCTCGCCTTCGCCCGCGACTACCGGCCCGACCTCGTCCTCTCCGACCCGCTGGACTACAGCGGCCTCGTCATCGGCGGCGCCCTGGGGATCCCGGTGGTCCACCACCGCTGGGGAGTCGACCCCGTCGGCACCCCCCGGATCCCCGCCGCCCGCGAGGAACTGGCCGACTTCTGCCGGACGCTGGGCCTGGACACCCTCCCGGACCCCGCCGCCGTGCTCGACCCGTGCCCCGCCGCTCTCCAACTGCCCGGGATACGCCCGGGGACCCCGGTGCGGTACGTGCCCTTCAACGGCAGCGGGGCGATGCCCGACTGGGTGCGCGCGGAGTGGGGCGCCCCGCGCACCAGCACCCGGCGGGTCGTGGTCTCCCTGGGCCGGCGGACCCTCGCCTACCACGGAGTTCCGTTCGTCAGGGCCCTGCTGCACGCCCTGGCGGGGGTGCCGGACATCGAGCTGATCGCCACCGTCGGCGCCGAACACCGGGCCGCGGTGGGACCCGTACCGGCCCCCGTGCGGATGCTGGACCCCTTCCCGCTGCACGCGGTGCTCGGCTCCTGCGACGCGATCGTCACCCACGGCGGATCGGCCACCACCATGACCGCCACCCTGCACGGGGTACCCCAACTGGCCCTGCCGCAGATGGCCGACTGCTTCGCGCACGGCGAGCGGCTCGCCGCCTGCGGGGCCGGAATCAGTCTGGCCACCGTCGCCGAGCAGGACGACCCCGCCGTACTGCGCGCGTCCCTGTCCCTGCTGCTGGACGACCCCTCGTACGCCGCCGGGGCGTCCCGGCTCCGTGCCGACATGGAGCGCATGCCCAGCCCCGCGGAGGTCGTCCCCGAACTGGAACGGCTCGCCGGGAAGGCGTCCCCGGCCTCCCTCTGA	MRVLVMTTPDPSHLPPLAPVAWALRAAGHEVLVAGQPDSAESARTTGLSMVAFGEPFDTEQLVLNSLAPGKRPLECRPGSAPGTAPPVKGGFGGVWIERARAMAGEYLAFARDYRPDLVLSDPLDYSGLVIGGALGIPVVHHRWGVDPVGTPRIPAAREELADFCRTLGLDTLPDPAAVLDPCPAALQLPGIRPGTPVRYVPFNGSGAMPDWVRAEWGAPRTSTRRVVVSLGRRTLAYHGVPFVRALLHALAGVPDIELIATVGAEHRAAVGPVPAPVRMLDPFPLHAVLGSCDAIVTHGGSATTMTATLHGVPQLALPQMADCFAHGERLAACGAGISLATVAEQDDPAVLRASLSLLLDDPSYAAGASRLRADMERMPSPAEVVPELERLAGKASPASL	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	96.63	gnl|BL_ORD_ID|1253|hsp_num:0	1367			294	1143	erythromycin; tylosin
BGC0001438.1|Warkmycin_11 # 11564 # 12682 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=AGA;rbs_spacer=8bp;gc_cont=0.747	BGC0001438.1|Warkmycin_11 	11564	12682	-	Loose	700	55.8398	mgtA	34.65	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	GTGACCCACGCGGGGCTCATGCCGGTACCGCTGCTCGAAGCGATGGACATGACCGTCCGGGGCCGGCTGCACAACTACCGCAAGGCAGAGGTGGGGACCTGGCCGTTCGCCACCCCGCCCCCGCACCCGCTCACCGGCGAACCGCTGCGTTCCCTCGACGAGTTCGACATGGCGGACTGGTCGGCCAGGAACCGCGACTGGGCGGTCGGCGTCGTCGACCGCAGCGCCGACGCGGCCGTGGACTTCGCCCGCGGCTGGCGGCCCGACCTGGTCGTGCACGACCTGATGAGCCTGGAGGGCCCCCTGGTCTCAGGGGCGCTGAAGATCCCCGCCCTGCTGCACCTGTGGGGGCCGTGCGGACCCCAGGACCCGGTGCCCGGAGCCCCGCCCGGATCGAGCTTCGTCCCGATGGACCCGGTCGGGGCCTTCGAGCGGCACGGCGCGGGACCGATGGACGCCGACGTCTACACCCACGTCATCGACCCCTCGCCGATCTCCGTACAGCCGCCGCTGAAGGCCGAACGGATCCCGGTGAGGCACCTGCCGTACAACGGACCGGGGGCCGTCCCGCCCCGGCAGTCGCCCCGCGAGGACGACCGGCCCCGGGTGTGCGTCGTCTGGGGCACCTCCGTCAGCGGGGTGCACGGACCCGCGTCGTTCGCCGTGCCCCGCGTCGTCGAGGCCCTGTCCGACATCGACGCCGAGGTGCTGCTCACCCTCACGGGCGAGGACCGCGCCCGGGTGGAGAGCGGCCCCGCGCTGCCGCCGCACGTGCGGCTGCTGGAACGCACCCCGCTCAGCCTGCTGCTGCCGGAGTGCGACCTGGTCGTCCACCACGGCGGCGCGGGCTGCACCATGACCGGACTGGCCGCGGGCATACCGCAGTTGGCGATCCATGCCGGATCCGACCAGGAAGTGATCGCCGACCGGGTCGCCGGGGCGGGCGCCGCCCGCTCCCTGGTCAACGCCGAAGCGGACGCGGCGGCCGTCCACCGGGCCGTCACCCGGCTGCTCGGCGACCCGGCCCACCGGGCCTCCGCCCGCGCCCTGAGGGACGAGATGGAGTCCCTGCCCACCCCCGCCGACCTGGTGTCCGTCCTGTCCGGGCTCGTCGGCTGA	MTHAGLMPVPLLEAMDMTVRGRLHNYRKAEVGTWPFATPPPHPLTGEPLRSLDEFDMADWSARNRDWAVGVVDRSADAAVDFARGWRPDLVVHDLMSLEGPLVSGALKIPALLHLWGPCGPQDPVPGAPPGSSFVPMDPVGAFERHGAGPMDADVYTHVIDPSPISVQPPLKAERIPVRHLPYNGPGAVPPRQSPREDDRPRVCVVWGTSVSGVHGPASFAVPRVVEALSDIDAEVLLTLTGEDRARVESGPALPPHVRLLERTPLSLLLPECDLVVHHGGAGCTMTGLAAGIPQLAIHAGSDQEVIADRVAGAGAARSLVNAEADAAAVHRAVTRLLGDPAHRASARALRDEMESLPTPADLVSVLSGLVG	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	89.00	gnl|BL_ORD_ID|2293|hsp_num:0	515			885	1188	erythromycin; tylosin; azithromycin; methymycin
BGC0001438.1|Warkmycin_12 # 12900 # 13481 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GAGAGA;rbs_spacer=4bp;gc_cont=0.682	BGC0001438.1|Warkmycin_12 	12900	13481	+	Loose	375	55.0694	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	44.29	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCCGAGAACGGTGCCCGGAAGAGCCGCGGGGAGACCCGTCGGCGCATCCAGGAGGTGGCCCTCGACCTCTTCGCCGAGCAGGGTTACGAGAAGACCTCCCTGCGGGAGATCGCCGAGGTGCTCCAGGTCACGAAGCCCGCGATCTACTACCACTTCCAGTCGAAGGAGGAGATCCTCCTCAGCATCTTCCAGAACCTGGGGCGCCCGGTGGCCGACGCCATCGCGTGGGGCGAGGTGCAGCCCAGGTCCCTGGAGACCAAGCGGGAGCTGCTGCGCCGGTACGGGGCCGCGCTCGACGCCACGGTGCCGCTGTTCCGGTTCATGCAGGAGAACGAGGCGACGCTCCGCGATCTGGAGGTGGGGCGGGAGTTCAAGGACCAGATGACCGCCATGGGCGAGCTCCTCAGCGATCCGGGCTCCTCACTCGTGGCGCAGTTGCAGTGCATGGGCGCTCTGCTCACCCTGCATTTCGGCACCTTCGCGCTGCCGCACTTCGAGGGTTCCGACGAGGAGAAGCGCGAGGCGCTGCTCTCCATCGCGACGGAGATGGTGGAGCGGGCGCACGGCCCGCAGGACTGA	VAENGARKSRGETRRRIQEVALDLFAEQGYEKTSLREIAEVLQVTKPAIYYHFQSKEEILLSIFQNLGRPVADAIAWGEVQPRSLETKRELLRRYGAALDATVPLFRFMQENEATLRDLEVGREFKDQMTAMGELLSDPGSSLVAQLQCMGALLTLHFGTFALPHFEGSDEEKREALLSIATEMVERAHGPQD	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	89.77	gnl|BL_ORD_ID|2090|hsp_num:0	2306			3	213	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001438.1|Warkmycin_13 # 13535 # 14338 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.724	BGC0001438.1|Warkmycin_13 	13535	14338	-	Loose	450	26.5646	OXA-184	24.71	3001476	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCCGCCCCAGTGCAGTGGATCCCCGAGGACACCGACCGCGAGCGCGCCAGCGCCGCCCGGGCGTACGACTACCTGCTGGGCGGCAGCCACCACTTCGAGGCGGACCGCGCCCTCGGCGACCAGGTGCTCTCCGTCCTGCCCGCGAACATCATGGCCCGGCAGAACAGGGACCTCCTCGGGCGCATGGTGCGCCACCTGATCGACGCCGGCGTCCGGCAGTTCCTCGACCTCGGCTCGGGGCTGCCCGTCATGGGGCATGTCCACGAGATCGCCCGGGACAGCGGCCGGATCTGTCGCGTGGTCTACGTGGACAACGAACCGGCCACGATCGCCCACTCCGGACTCCTGCTGCGCGGCGTCCCGGGAACGGCCCTGGTCGGCGCGGACGTACGGGACCCGGACGCCGTACTGGGAGCCGATGCGACCCGGGAGCTGATCGACTTCGACGAGCCGGTCGGGCTGCTCATGCTCGGGGTCACCCAGTTCCTCCACGACGAGGACGACCCCTGGGGCCTCACCGCCCGCTACCGCGACGCCCTCGCCCCCGGAAGCCACCTCGCCCTGTCCTGCTTCACCTGGGACAACGACCCGGACACCATGCGCAGGACCGTCGAGATGTTCCGGGCGAGCGGCCGGACCCCGATCGTCCCGCGCACCGGCGCCGAAGTACGCCGCCTCACCGGCGACTTCACCCTCCTCGACCCGGGCCTCGTGTACGCGCCCCGGTGGCGGCCCGACGCCACGTCCGGCGCCGAGCAGGAGCGGTCCAACCTCTACGCGGCCCTCGCCCGCAAACCGTGA	MSAPVQWIPEDTDRERASAARAYDYLLGGSHHFEADRALGDQVLSVLPANIMARQNRDLLGRMVRHLIDAGVRQFLDLGSGLPVMGHVHEIARDSGRICRVVYVDNEPATIAHSGLLLRGVPGTALVGADVRDPDAVLGADATRELIDFDEPVGLLMLGVTQFLHDEDDPWGLTARYRDALAPGSHLALSCFTWDNDPDTMRRTVEMFRASGRTPIVPRTGAEVRRLTGDFTLLDPGLVYAPRWRPDATSGAEQERSNLYAALARKP	MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN	107.66	gnl|BL_ORD_ID|1030|hsp_num:0	1126			114	354	cloxacillin; oxacillin; cefalotin
BGC0001438.1|Warkmycin_14 # 14338 # 15405 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.759	BGC0001438.1|Warkmycin_14 	14338	15405	-	Loose	525	27.335	DHT2-1	34.44	3006872	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	DHT2 beta-lactamase	ATGAGCGCATCCCGCCCCCCGGCGCGGTCCGGTCCCGTCCGGGTCGGCGTCCTCGGCACGGCGTCCATCGCCCGCCGCCGACTGCTGCCCGCACTCGCCGCCTGCCCGGACACCCGGGTCGTCGCCGTGGCGAGCCGCGCTCTCCCCACCGCCGAGGAGGCCGCCGCGCCCTATGGCTGCAAGGCCGTGGAGGGGTACGGTGCGCTGCTCGCCCGGGACGACGTCGACGCCGTCTACGTGCCGCTTCCCGCCGCCCTGCACGCCCCGTGGGTGCGCGCCGCGCTGACGGCGGGCAAACACGTACTGGCGGAGAAGCCGCTGAGCACCGACGCCGCGACCACCCGCGGGCTCCTCGCGCTCGCCCGCGACAAGGGCCTCGTGCTGAGCGAGAACGTGATGTTCGTGCACCACGCCCGGCACGCCGAGGTCCGCCGCCTGATCGAGGACGGCGCGATCGGCGACGTACGGGCGTTCCACGCGGCGTTCACCGTGCCGCGCCCGCCCGACGGCGACATCCGCCACAGCGCCGGACTCGGCGGCGGAGCCCTCGGCGACATGGGCGTGTACCCGGTGCGCGCCGCACTGCACCTGCTGGGCAACGGCCTCCGGGTCGCGGGCGCGGTGCTGACCACCGCCCCCGGGAGCGAGGTGGAGACCTCCGGCGCGGCGCTGCTGCGCACCCCCGACGGCGCGAGCGTCCACTGCGCCTTCGGCATGGGGCAGAGCTACCGCTCCCTGTACGAGGTGTGGGGGGAGCGCGGCCTGATCCGCGTGGAACACGCCTTCACCCCGCCCGCCGACCATGTGCCCGTGCTGCGCGTCGAACGGGACGGCAGGGCCGAGGAGGTCGAGCTGGCGCCGGACGACCAGGTGGCCAACACCGTCTCGGCGTTCGCGGCCGCCGTACGCGCGGGCCGCTCCCCGGACGAAGCGGTGACGCTGCGCCAGGCGGAGCTGCTCGACGCCGTCCGCCGGGCGGCGGGCCGACCGGAAACCGGTCCGGAGAACCCCGACGGCCCAGGCAGCCCCGACAACCCCGACAACCCCGACAAGCCAAGGAGTCAGTGA	MSASRPPARSGPVRVGVLGTASIARRRLLPALAACPDTRVVAVASRALPTAEEAAAPYGCKAVEGYGALLARDDVDAVYVPLPAALHAPWVRAALTAGKHVLAEKPLSTDAATTRGLLALARDKGLVLSENVMFVHHARHAEVRRLIEDGAIGDVRAFHAAFTVPRPPDGDIRHSAGLGGGALGDMGVYPVRAALHLLGNGLRVAGAVLTTAPGSEVETSGAALLRTPDGASVHCAFGMGQSYRSLYEVWGERGLIRVEHAFTPPADHVPVLRVERDGRAEEVELAPDDQVANTVSAFAAAVRAGRSPDEAVTLRQAELLDAVRRAAGRPETGPENPDGPGSPDNPDNPDKPRSQ	MSSIVRGVRAAVVASAISLAAAFACLPLAAADATREPVLPQSGRYEVPDSWRQPIAPVRIADHTWYIGTENLSAVLVTTPQGAVLIDGGMPQAADMLLQRMRDVGIAPGDLRWILVSHAHADHAGPVAKVKRATGARIAANAESAAMLARGGTDDIHFGDDITFPPAQADRLLQDDEVVQVGGIALTGHVTPGHTPGSTSWTWTDTKDGKPVRIAYADSLSAPGYKLIGNPRMPRIVEMYEATFAKVRALPCDLLLTPHPDASGWTPADAANPHPSPKTCAAYADEMEAKFDAELAKQRAAK	117.55	gnl|BL_ORD_ID|3515|hsp_num:0	4584			162	396	
BGC0001438.1|Warkmycin_15 # 15402 # 16811 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.712	BGC0001438.1|Warkmycin_15 	15402	16811	-	Loose	650	30.0314	EreA	26.4	3000361	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGCCCGCCATGTCCGCAACCACGCTCACCCACCCCGTGCTCCGGCCGCGCCGGGAGGCCTCGGCCGTCGAGCGGTACGCCCGGTCCGCCGAAGCCCTCGAAGGGGCGGCGATCCGCACCGCCGACGTGCCGGCCTGGCTGGAGGAACGCAGGCGCGCCCACGACTTCCGGGTCGACCGCATCCCGTTCGCCGAACTCCGCGGCTGGGACTTCGCACCCGACACGGGCAACCTCGTCCACAGCAGCGGAAGGTTCTTCTCCGTCGAGGGACTCGACGCCACGGTCACCGACGACGACGGGACCGTGACGACCTGGCGTCAGCCGATCATCAAGCAGCCCGAGGTCGGCATCCTGGGGCTGCTGGTCAAGGAGTTCGACGGCGTTCCGCACTTCCTCATGCAGGCCAAGATGGAGCCCGGCAACCCCAACCTCCTCCAGCTCTCGCCGACCGTCCAGGCGACCCGCAGCAACTACACGGGCGCCCACCGGGGCGCGGCCGTCCGGTACATCGACCACTTCGTCAGCCCCGAGGCCGGCAGCGTCGTCGCCGACGTGCTGCAGTCCGAGCACGGCTCCTGGTTCTACCGCAAGAGCAACCGCAACATGATCGTCGAGACGACCGCCGACGTGGAGCCGCACGAGGACTTCCGCTGGCTCACCCTGGGGCAGCTGGCCCAGCTCCTCCACCAGGACGACGTGGTGAACATGGACACCCGGACCGTGCTGTCCGCGGTGCCGTACGCCGACCCGCACGGCAGGGCCAAGCTCCGCGACGCCGAACTGCACTCGTGGTTCACCGGCCAGCGTGCCCGGCACACCGTCAGCGCCGAACGCGTCCCGCTCGCGGACGTCACCGGCTGGACCCGCGGCGAGGAGACCATCGAGCACGACGAGGGGCGGTACTTCAAGGTGGTCGCCGTCTCCGTCCGGGCCGGCAACCGCGAGGTCACCGGGTGGACCCAACCGCTGTTCGAACCGGTGCGGAACGGTATCGCCGCCTTCGTCCTGCGCCACTTCGACGGCGTGCCGCACGTGCTGGCGCACGCCCGGGTCGAGGGCGGCTTCCTGGACGCGGTCGAACTGGGCCCCACGGTCCAGTACACCCCCGCCAACTACGACCACCTGCCGGTCGCGGAACAGCCCCCGTTCCTCGACCTCGTCCGTACGGCGCGCCCCGACCGCATCCGCTACGAAGCGGTGCACTCGGAGGAGGGCGGCCGCTTCCTCAACGCCGGGAGCAGGTATCTGGTGGTCGAGGCGGACGAGACGCAGGCGCCGCTCGACCCGCCCCCCGGCTACCAGTGGGTCACCCCCGGCCAGCTCACCTCGCTCGTCCGGCACGGCCACTACCTCAACGTGCAGGCCCGCACCCTCCTCGCCTGCCTCGGCGCCATGGGGCTCACCTCATGA	MPAMSATTLTHPVLRPRREASAVERYARSAEALEGAAIRTADVPAWLEERRRAHDFRVDRIPFAELRGWDFAPDTGNLVHSSGRFFSVEGLDATVTDDDGTVTTWRQPIIKQPEVGILGLLVKEFDGVPHFLMQAKMEPGNPNLLQLSPTVQATRSNYTGAHRGAAVRYIDHFVSPEAGSVVADVLQSEHGSWFYRKSNRNMIVETTADVEPHEDFRWLTLGQLAQLLHQDDVVNMDTRTVLSAVPYADPHGRAKLRDAELHSWFTGQRARHTVSAERVPLADVTGWTRGEETIEHDEGRYFKVVAVSVRAGNREVTGWTQPLFEPVRNGIAAFVLRHFDGVPHVLAHARVEGGFLDAVELGPTVQYTPANYDHLPVAEQPPFLDLVRTARPDRIRYEAVHSEEGGRFLNAGSRYLVVEADETQAPLDPPPGYQWVTPGQLTSLVRHGHYLNVQARTLLACLGAMGLTS	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	115.52	gnl|BL_ORD_ID|917|hsp_num:0	991			168	528	erythromycin; roxithromycin; clarithromycin
BGC0001438.1|Warkmycin_17 # 17676 # 18986 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GAGA;rbs_spacer=4bp;gc_cont=0.693	BGC0001438.1|Warkmycin_17 	17676	18986	-	Loose	1000	26.1794	efpA	27.54	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGACCCCCTCGATCGCAAGGCGCTGTTGCTGGACGAGGTACGCAAGTACCACCACGAGGCACAGCCGGACCGGCGGTTCGTGCCGGGCGTCACCGAGATCTGGCCCTCCGGCGCGGTACTGGACGAGGACGATCGAGCGGCGCTCGCCGAGGCGGCGCTGGACATGCGCATCGCCGCGGGAGTGAGTTCGCGCAGATTCGAGTCCGCCTTCGCCCGCCGGATGGGACGCCGCAAGGCGCATCTGACCAACTCGGGGTCGTCCGCGAACCTGCTCGCGGTCTCGGCGCTCACCTCGCACCTGCTGGAGGACCGGCGGCTGCGGCCGGGGGACGAGGTCATCACCGTCGCGGCCGGCTTCCCCACCACCGTCAACCCGATCCTCCAGAACGGGCTCATACCGGTCTTCGTCGACGTGGAGATCGGCACCTACAACACCACCGCCGACCGCGTGGCCCGCGCCATCGGCCCGCGGACCAGGGCGATCATCATCGCGCACGCCCTCGGCAACCCCTTCGAGGTCACCGAGATCGCCCAACTGGCCTCCGACCACGACCTGTTCCTCATCGAGGACAACTGCGACGCCGTCGGGTCGCTCTACGACGGGCAGCTCACCGGCACCTTCGGAGACCTGTCGACCGTCAGCTTCTACCCCGCACACCACCTGACGATGGGCGAGGGCGGCTGCGTGCTGACCGCCAACCTGGCGCTGGCACGCATCGTGGAGTCCCTGCGGGACTGGGGCCGCGACTGCTGGTGCGAGCCGGGCGAGAGCGGGAAGTGCCTCAAGCGGTTCGAGTACCAGATGGGGACCCTCCCCGCCGGCTACGACCACAAGTACATCTTCAGCCACGTCGGGTACAACCTGAAGGCGACCGACCTCCAGGCCGCCCTGGGCCTCAGCCAGCTGGCCAAGCTGGACGAGTTCTGCGCGGCGCGCCGCCGCAACTGGCGGCGGCTGCGCGACGGGCTGGCGGACGTGCCCCACCTGGTGCTGCCCGAGGCCACCCCGCGCAGCGACCCGAGCTGGTTCGGCTTCGTCCTGACGATCGATCCCGAGGCCCCCTTCAGCAGGGCCGAGGCGGTCGACTTCCTGGAGAGCCGCAAGATCGGCACCAGGCGGCTCTTCGCCGGCAACCTCACCCGCCACCCCGCCTACATCGGGCAGCCGCAGCGTGTGGTGGGCGAGCTGACCAACAGCGACCTCATCACCGACCAGACCTTCTGGATCGGGGTCTATCCCGCCCTCACGGACGAAATGATCGACTACGTCGTCGCGTCGATCCGGGAGTTCGTACAGGCCCGCGGATGA	MDPLDRKALLLDEVRKYHHEAQPDRRFVPGVTEIWPSGAVLDEDDRAALAEAALDMRIAAGVSSRRFESAFARRMGRRKAHLTNSGSSANLLAVSALTSHLLEDRRLRPGDEVITVAAGFPTTVNPILQNGLIPVFVDVEIGTYNTTADRVARAIGPRTRAIIIAHALGNPFEVTEIAQLASDHDLFLIEDNCDAVGSLYDGQLTGTFGDLSTVSFYPAHHLTMGEGGCVLTANLALARIVESLRDWGRDCWCEPGESGKCLKRFEYQMGTLPAGYDHKYIFSHVGYNLKATDLQAALGLSQLAKLDEFCAARRRNWRRLRDGLADVPHLVLPEATPRSDPSWFGFVLTIDPEAPFSRAEAVDFLESRKIGTRRLFAGNLTRHPAYIGQPQRVVGELTNSDLITDQTFWIGVYPALTDEMIDYVVASIREFVQARG	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	82.26	gnl|BL_ORD_ID|2188|hsp_num:0	2427			1191	1395	rifampin; isoniazid
BGC0001438.1|Warkmycin_18 # 18997 # 19995 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.702	BGC0001438.1|Warkmycin_18 	18997	19995	-	Loose	1200	52.373	arnA	26.39	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGAATGCTGGTCACCGGCGGCGCCGGTTTCATCGGCTCCCGCTTCGTCAGGATGCTGCTGGAGAACCGGTTCGAGGGCTGGGAGGACGCCGAGGTCGTCGTCCTGGACGCCCTCACCTACGCGGGCAACCGCGCCAACCTGCCCGCGAGCCACCCGCGCCTGCGCTTCGTACGGGGCGACGTGTGCGACACGGAGACCGTGCGGGAGCTGGCCGACGGAGTCCACGCGGTGGTGCACTTCGCCGCCGAGTCCCATGTGGACCGCTCCCTCACCGGCCCCGCCGAGTTCTACCGCACCAATGTGCTGGGCACGCAGTCCGTACTCGAAGCGGCGCTGCGCGCGGACGTGGAACGCGTCGTCCACGTCTCCACCGACGAGGTGTACGGATCGATCTCCGAGGGGTCCTGGACCGAGGACCGGCCGCTGGCCCCCAACACGCCCTACGCGGCGTCCAAGGCGGCCTCCGACCTGGTGGCCCGCAGCTACTGGCGCACCCACGGCCTGGACGTCTCGGTCACCCGCTGCTCCAACAACTACGGTCCGCGCCAGCACCCCGAGAAGCTGATTCCGCTGTTCGTGACCCGGCTGCTGCGCGGCCTGCCGGTGCCGCTGTACGGGGACGGCGGCAACATGCGCGAGTGGCTGCACGTGGACGACCACTGCCGGGCCCTCCACCTCGTACTGAACAAGGGCCGCTCGGGCGAGACGTACAACGTCGGCGGCGGCAACGAGTGGACCAACCTGGACCTCACCGGACGGCTGCTCGACCTCTGCGGCGCCGACGAGTCGCTGGTGCGCAGGGTGGCTGACCGCAAGGGGCACGACCTGCGCTACTCGCTGGACGACACCAAGATCCGCGAGGAGCTGGGGTACGCGCCGCAGATCACGTTCGATCAGGGGCTGGCCGAGACAGTCGCCTGGTACCGGGAGCACACCGACTGGTGGCAGGACGCGGCGGCCGTGGCCGAGCGCCCGGACCTCAGCGTCCTGACCTGA	MRMLVTGGAGFIGSRFVRMLLENRFEGWEDAEVVVLDALTYAGNRANLPASHPRLRFVRGDVCDTETVRELADGVHAVVHFAAESHVDRSLTGPAEFYRTNVLGTQSVLEAALRADVERVVHVSTDEVYGSISEGSWTEDRPLAPNTPYAASKAASDLVARSYWRTHGLDVSVTRCSNNYGPRQHPEKLIPLFVTRLLRGLPVPLYGDGGNMREWLHVDDHCRALHLVLNKGRSGETYNVGGGNEWTNLDLTGRLLDLCGADESLVRRVADRKGHDLRYSLDDTKIREELGYAPQITFDQGLAETVAWYREHTDWWQDAAAVAERPDLSVLT	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.15	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1746	polymyxin B
BGC0001438.1|Warkmycin_19 # 20091 # 21140 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGTGA;rbs_spacer=11bp;gc_cont=0.725	BGC0001438.1|Warkmycin_19 	20091	21140	-	Loose	600	27.7202	Rm3	34.78	3003894	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	Rm3 family beta-lactamase	ATGAAGTACGACCTCCTCGGCAGGACCGGCCTACGGGTCTCCGAACTCTGCCTGGGCGCCGGGACCTTCGGGGTCGAGGGGTGGGGCGCCTCGAAGGAGGACGCCTCGCTCATGGTCGACCGCTACGCACAGGCGGGCGGCAACTTCATCGACACCGCGAACGTCTACGGCGGGGGACGCTCGGAGGAGTGCCTCGGCGAGGTACTGGCCGGCCGGCGCGACGAGTTCGTGCTGGCCACCAAGTACAACACCATGACCCGGCCGGGCGACGTGAACTCGGCGGGCAACCACCGCAAGAACCTCGTCGCCTCGCTCGAGGACAGCCTGCGGCGGCTGCGGACCGACCGGGTGGACGTGCTCTGGCTGCACGCCCGGGACGCGTTCACCCCCGTCGAGGAGGTCATGCGCGCCCTCGACGACCAGATCCGGGCCGGCAAGGTCCTCTACGTGGGAGCATCCAACTGGCCCGCCTGGGAGGTCTCCCGCGCCAACATGCTCGCCGAACTGCGCGGCTGGTCGGCGTTCGCGGGCCTCCAGGTCCGCTACAACCTGCTGGAACGCACCGCCGAACGGGACCTGCTCCCGATGGCCTCCGCCTGCGACGTCAGCGCCTTCGCCTGGGGTCCGCTGGCCGAGGGACGGCTGACCGGCAAGTATCTGCGCGGGGAGAGCGGCCGGCTCACGGTGGAGAACTGGGCGGGCGACGACGAGCACGACACCGCCGTCGTCCGGGAGGTCGTGGCCGTCGCCGAGGAGGGCGGCTGGACCCCCGCGCAGGTCGCACTCGCCTGGCTGCGCGCCCGGCCCGAGGCCGTCCTGCCGATCCTCGGCGCGACCCGGCCCGGACAGCTCCAGGACTCCCTCGCCGCTCTCGACGTCCGGCTCGACGAGGAGCAGACCCGGCGGCTCGACGACCTCAGCGAGGTCTCCCTCGGCTTCCCCCGGGAGCTGATGCGCCACGGCAAGTTCACCAAGGGCGCCTACAGCGACCGCTGGCCGGACCTGGAACGCCGCCGGGGGCCGGGACGCACGGTCGCCACCCTCCTGTGA	MKYDLLGRTGLRVSELCLGAGTFGVEGWGASKEDASLMVDRYAQAGGNFIDTANVYGGGRSEECLGEVLAGRRDEFVLATKYNTMTRPGDVNSAGNHRKNLVASLEDSLRRLRTDRVDVLWLHARDAFTPVEEVMRALDDQIRAGKVLYVGASNWPAWEVSRANMLAELRGWSAFAGLQVRYNLLERTAERDLLPMASACDVSAFAWGPLAEGRLTGKYLRGESGRLTVENWAGDDEHDTAVVREVVAVAEEGGWTPAQVALAWLRARPEAVLPILGATRPGQLQDSLAALDVRLDEEQTRRLDDLSEVSLGFPRELMRHGKFTKGAYSDRWPDLERRRGPGRTVATLL	MSLTPPRALVLALLLASPGTQAQTPAPATPPTPGCEVCATWNADQAPFRLFGNTYYVGMKGLSSVLVTSPQGHVLIDGGLPESAPKIIANIGALGFRIEDVKLILNSHGHIDHAGGLAELQRRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGQFNVGPVYLTAHATPGHTPGGLSWTWQSCDGPRCLNMVYADSINAVSRPGFKFSASSEYPNALADLRHSFETLEKLPCDVLISAHPEASQLWQRLEASATGGSDAFVDPQACRAYVAAARTLLDSRLDQEKQQ	115.56	gnl|BL_ORD_ID|4702|hsp_num:0	2375			612	750	
BGC0001438.1|Warkmycin_21 # 21791 # 22984 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGA;rbs_spacer=6bp;gc_cont=0.689	BGC0001438.1|Warkmycin_21 	21791	22984	-	Loose	175	30.0314	vanT gene in vanG cluster	35.29	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGCGCCATCGAACGCCACTTCCAGACTTCCCTCGCTCACCGGGATGCGTTTTCTCGCCGCCCTGATGGTGTTCTCCGTGCACGGCGCCGCCGCCGGCGTCTTCAAGGACCAGGGGGTCGCAGCCGACTACTACCGCTGGTTCGGCAACGCCGGCGCCGTCGGCGTCTCCTTCTTCTTCATGCTCAGCGGCTTCGTCCTCACCTGGTCGGTGCGTCCCGCCGACACCGTCCGCGGATTCTGGCGGCGGCGCCTGCTGAAGATCTTCCCCAACCATCTGGTGACGTTCGTCGTGGCCATCGTCCTGCTGACGGTGACCAGCACCGCGGTCGCCTTCCCCGAGACGCTCGCCAACCTGTTCCTGGTGCACGCCTGGGTGCCCGACAGCGGCTACGTCGAAACGGCCAACACCGTCAGCTGGTCGCTCTCCGTGGAGCTCCTCTTCTACCTGTCCTTTCCGCTGCTCATCAAGGGCGTGAGCCGGATCGCGCCCGCCGTGCTCTGGTACGCGGCGGGCGGCATCGTGCTGGTCATCATGCTGATGCCGCTGATCGCGCAGACGCTGCTGCCGGACACCCCGGGCTTCATGTTCATGCAGATCTCCTGGACCCAGATCTGGTTCGTGTACGTCTTCCCCGTCGCCCGGCTCCTCGAATTCGTGCTCGGCATGCTGCTGGCGCGCATCGTGCTGTCCGGCCGGTGGATCGGGCTCGGCGTGCTGCCGCCGGCCCTCCTGACGGTCGTCGCCTACGTGGGCGCCGTACAGATCGACCACAACCCGCTCTACAACTACGTGGCGATCACCGTCGTCCCGCTGGCCCTGCTGATCCCGGCAGCCGCCGCGGCCGACGTCCGGGGCCGCGAGAGCCTGCTCAGCAAGCGCCCCATGGTCTGGCTCGGGGAGATCTCGTTCGCCTTCTACTGCGTGCACTACCTGATCCTGATCTACGGTCACCGGCTGTTCGGCTCGGACCCCAACATCTTCGGCAAGCCCTCCGGACCCGCCTGGAGCACACCCGGCGGCCTGCTCTTCCTGGCCGCGGCCCTCGTCGTCTCCGTGCTCGCCGCGTGGGCCCTGTACGCGATCGTCGAACGCCCCGTCATGCGCCGCTGGGGCCGCCCGCCGGGCCCCCGGCACACCGAGCAGGCGGCCGTCCGGCCGGAACGGGCAGCCGAAGCCCCCGCGGCCCACTGA	MAPSNATSRLPSLTGMRFLAALMVFSVHGAAAGVFKDQGVAADYYRWFGNAGAVGVSFFFMLSGFVLTWSVRPADTVRGFWRRRLLKIFPNHLVTFVVAIVLLTVTSTAVAFPETLANLFLVHAWVPDSGYVETANTVSWSLSVELLFYLSFPLLIKGVSRIAPAVLWYAAGGIVLVIMLMPLIAQTLLPDTPGFMFMQISWTQIWFVYVFPVARLLEFVLGMLLARIVLSGRWIGLGVLPPALLTVVAYVGAVQIDHNPLYNYVAITVVPLALLIPAAAAADVRGRESLLSKRPMVWLGEISFAFYCVHYLILIYGHRLFGSDPNIFGKPSGPAWSTPGGLLFLAAALVVSVLAAWALYAIVERPVMRRWGRPPGPRHTEQAAVRPERAAEAPAAH	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	55.76	gnl|BL_ORD_ID|1522|hsp_num:0	1561			39	180	vancomycin
BGC0001438.1|Warkmycin_22 # 23071 # 24342 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.756	BGC0001438.1|Warkmycin_22 	23071	24342	-	Loose	600	78.9518	Acinetobacter baumannii AmvA	31.43	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGCGGCCCCCCGTCCCCTCGAAGGCCGGCCCGTCGCCCGGCGCCCCGCCCCTGCCGTGGGCAGGCCGCTTCCTGCTGCTCGTCCTGGCCGGCAACATGCTCATCGACGGTCTCGAAGTGTCCGTGGTCGTCGTCGCCCTGCCGTCGATCGGCGCCGACCTCGGACTGTCCCCCTGGCAGGTCCAGTGGGCCATGGGCGGGTTCGCGCTCGGCTTCGGAGCCCTGCTCCTGCCGGGCCGGCGCCTGGTGGCGCGGTACGGACACCGCCGGCTGTACCTGGGGGCGCTGGCCCTCTTCGTCCTCGCGTCGCTGGCCGGCGGGCTCACGGACGACCCGCTGCTCCTCCTGGGCAGCCGGATCGTCAAGGGCATGTGCGCCGCGCTGACCGCGCCCACCGGCCTGGCCATCATCTCCATCACCTACGAGGAAGCGTCGGCGCGCGCCCGTGCCCTGTCCGTGTACACCTTCTGCGGCGGCATCGGATTCACCACGGGCCTGCTGCTGGCGGGAGTCCTCGCACCGCACGACTGGCACTGGACCTTCGTCGCCACGGCCCCGGTCGCCGCGGTGCTGCTCGTCCTGGCGGCCGCGGCCGTGCCCCGGCAACAGCCGGGGCCCGACCATCCGATCGCTCCGACGGTGCGCCGGCTGCTGGGCAACGGAGCGCTGCTGCGTCCGGCGCTCGGTGCGGCGATCCTCAACGGCACCTACCTGGGGCTGCTGTCCCTGATGGCCCACCAGGCATGGAACCTGCTGCACTGGAGTCCCTGGCAGACCGCGGCCGCCTTTCTCCCGGCCTGCCTCCCCCTGGCGGTGACAGCGCTCTCGGCCGGGCGCGCGGTGGCCCGGTTCGGCGCCCCCCGGCTCGTCGTCCTCGGCGCGGTGCTCCACCTCACGGGCCTGCTGCTGTACGCACGCCTCGACCTGCCGAGGTCCTACACCACGGACCTGCTGCCGACGCTGGCACTGGTCGGCATCGGCTTCGTACCGGCCTTCGCGGCGCTGAACGCGCAGGCGGGCCGGGCCGTCGGGACGGCCGACCGGGGGACGGCCACCGCCACCTACCAGACGGCGGTCCAGGCCGGAGCGGTCGCGGTGCCCGCCGCCGTGGCCGCGCTGCTCACCTTCGGGCCCGGGGACGGCGGTCCGGTGGGGGACGCCGCCCACCGGCCCGTCCTGCTCCTGCTCTGCGCCCTCGCGGCGCTGGGCCTGCTGGTCGCCCTGCGCGGCCTCACCGCCCGTCGCCCGGCCGTCGCCGACGACCGCTGA	MSRPPVPSKAGPSPGAPPLPWAGRFLLLVLAGNMLIDGLEVSVVVVALPSIGADLGLSPWQVQWAMGGFALGFGALLLPGRRLVARYGHRRLYLGALALFVLASLAGGLTDDPLLLLGSRIVKGMCAALTAPTGLAIISITYEEASARARALSVYTFCGGIGFTTGLLLAGVLAPHDWHWTFVATAPVAAVLLVLAAAAVPRQQPGPDHPIAPTVRRLLGNGALLRPALGAAILNGTYLGLLSLMAHQAWNLLHWSPWQTAAAFLPACLPLAVTALSAGRAVARFGAPRLVVLGAVLHLTGLLLYARLDLPRSYTTDLLPTLALVGIGFVPAFAALNAQAGRAVGTADRGTATATYQTAVQAGAVAVPAAVAALLTFGPGDGGPVGDAAHRPVLLLLCALAALGLLVALRGLTARRPAVADDR	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	85.98	gnl|BL_ORD_ID|2718|hsp_num:0	3280			57	579	erythromycin; acriflavine
BGC0001438.1|Warkmycin_23 # 24424 # 25185 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.706	BGC0001438.1|Warkmycin_23 	24424	25185	-	Loose	200	27.7202	vanH gene in vanF cluster	42.22	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGGGAAAGCTCGCGAACAAGACCGCACTCGTCACCGGGTCGAGCCGGGGCATCGGACGGGCGACCGCACTGCGGCTCGCGCGTGAGGGCGCCCTGGTGGCCGTGCACTACGCCACCGGCGAGGAAGCCGCCCTGAGCACGGTCGCCGACATCGAGGCGGCGGGCGGCCGCGCGTTCGCCGTCCGCAGCGAGTTCGGCGTCCCCGGCGACGTCGACACGCTGTTCGAGGCGCTGGAGAGCGGACTGAAGGAGCGGACCGGGGGCGCCACCCTCGACATCCTGGTCAACAACGCGGCCATCATGGGCGGTGTCCCCCCGGAGGAGGTCACACCCGAGCTGTTCGACCGGCTCTTCGCGATCAACGCGAAGGCGCCGTTCTTCATCGTCCAGCGCGCGCTCGGACTCCTCGCCGACGGCGGGCGCATCATCAACATCTCCTCCGGGCTCACCCGGTTCGCCAACCCCGAGGAGGCCGCCTACGCGATGACCAAGGGCGCGGTCGAACAGATCGCCCTGCACTTCGCCAAGTACCTGGGCGCCCGGGGCATCACCGTGAACAGCGTCGCCCCGGGGATCACCGACAACGGCAGCCCGGTGTTCGACATCCCGCAGGCGGTCGAGCAGATGGCCCAGATGTCGGCCTTCGGACAGGTGGGCAAGCCCGCGGACGTCGGTGACGTGGTGGCGTTCCTCGCCTCCGACGACGCCCGCTGGATCACCGGCTCCTTCATCGACGCCACCGGCGGCACACTCCTCGGCTGA	MGKLANKTALVTGSSRGIGRATALRLAREGALVAVHYATGEEAALSTVADIEAAGGRAFAVRSEFGVPGDVDTLFEALESGLKERTGGATLDILVNNAAIMGGVPPEEVTPELFDRLFAINAKAPFFIVQRALGLLADGGRIINISSGLTRFANPEEAAYAMTKGAVEQIALHFAKYLGARGITVNSVAPGITDNGSPVFDIPQAVEQMAQMSAFGQVGKPADVGDVVAFLASDDARWITGSFIDATGGTLLG	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	78.57	gnl|BL_ORD_ID|1652|hsp_num:0	1790			645	771	vancomycin
BGC0001438.1|Warkmycin_24 # 25260 # 26771 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.765	BGC0001438.1|Warkmycin_24 	25260	26771	-	Loose	600	293.123	Streptomyces venezuelae rox	42.13	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGTGAGCGCACCGGACATCGACACCCAGGTGCTCGTGGTGGGAGCCGGGCCGGTCGGCCTGATGCTCGCCGGTGAACTCGCCCTCGGCGGGGCCGACGTCGTCGTGCTGGAACGACGCACCGGCCCGCTCACCGAGTCCCGGGCCTCCACCCTGCACGCCCGCACGATGGAACTCCTCGACCAGCGCGGGCTGCTGGAGGAGCTGGGCACCCCGCCCGCCGGGGGCCCCGGACACTTCGGCGGCACACGCCTCGACCTCACCACGGACAGCCCGTACTCCGGCCAGTGGAAAGTCCCCCAGGTCCGCACCGAGGAACTGCTTGAGGGCTGGGCGACCCGGCTCGGGGCCCGCGTGGTCAAGGGCCACCGGCTGACGGATCTGAGGACCGCGCCGCACACCGTCGAGGCGACCGCCGAGGCGGAACCGGGACCCGGAGGGGCGGCGTCCGCGCTGCGCGTCCGGGCCGCGTACGTCGTCGGCTGCGACGGCGAGTCCAGCACCGTACGGGAGCTCGCCGGGTTCGCCTTCCCCGGCCGGGACGCCACCAGGGAACTGCTGCGCGCGGACGTGGCGGACGTGGAGGTGCCCGACCGGCGCTTCGAACGTCACCCCGGGGGACTGGCCATCTCGGCCCGGGGGCCCGGCGGCGTCACCCGGGTCATGGTGCACGAGTACGGGGCCGGCGTCGGCGGGGAGCCCGGACCCCCGTCGTTCGCCCGGGTGGCGGACACCTGGCGGCGGGTGACGGGCGACGACATCGGCGGGGGAACCCCCCTGTGGCTGAACTCCTTCGGCGACGCGCTCCGGCAGGCCGCCCAGTACCGCCGGGGCAGGATCCTGCTCGCGGGCGACGCCGCCCACCACCAGATGCCGGTGGGCGGCCAGGCCCTCAACCTGGGGCTGCAGGACGCCGCGAACCTCGGCTGGAAGCTCGCCGCCGAGGTCCGGGGGACCGCCGACCCCGGGCTGCTGGACAGCTACCACGCCGAACGCCACCCGGCCGGGCGGCGGGTGCTGGACAACATCGCCGCCCAGGCGCTGCTGCTGCTCGGCGGCTCCGGGACCGAACAGCTGCGCACCCTCTTCGGCGAACTCCTGCGGGAGCCCCGGGTACGCGCCCATCTCGCCGGGACCATCGCCGGCGTCGACGTACGGTACGCGGCCGGACCGGGCGCCCACCCCCTGGTCGGCGCCCGCGTCCCGTACCTCCGCTTCGGCACCGGCACCGATGCCGCCGCGGGGCCGGGCAGCACCTTCGCCGCTCTGCGGGCCGGTCGCGGAGTCCTCGTCGACCTGAGCGGCCGGCCGACCCCGCTTCGGGCGGCGGCGGAGCCGTGGCGGGACGGCCGGGTGGACGTGGTGACCGCGACGCCCGAACCGGGCGGCGCCGCACCGGAGTTCACCTCGGCGCTGCTGCGGCCGGACGGCCATGTGGCCTGGGCCGACGGCACCGTTCCGGAACTGGAGACGGCCCTGCGGCGCTGGTTCGGCCCGGCGGCGCGCCGGTAG	MVSAPDIDTQVLVVGAGPVGLMLAGELALGGADVVVLERRTGPLTESRASTLHARTMELLDQRGLLEELGTPPAGGPGHFGGTRLDLTTDSPYSGQWKVPQVRTEELLEGWATRLGARVVKGHRLTDLRTAPHTVEATAEAEPGPGGAASALRVRAAYVVGCDGESSTVRELAGFAFPGRDATRELLRADVADVEVPDRRFERHPGGLAISARGPGGVTRVMVHEYGAGVGGEPGPPSFARVADTWRRVTGDDIGGGTPLWLNSFGDALRQAAQYRRGRILLAGDAAHHQMPVGGQALNLGLQDAANLGWKLAAEVRGTADPGLLDSYHAERHPAGRRVLDNIAAQALLLLGGSGTEQLRTLFGELLREPRVRAHLAGTIAGVDVRYAAGPGAHPLVGARVPYLRFGTGTDAAAGPGSTFAALRAGRGVLVDLSGRPTPLRAAAEPWRDGRVDVVTATPEPGGAAPEFTSALLRPDGHVAWADGTVPELETALRRWFGPAARR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	105.67	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1419	rifampin; rifaximin; rifapentine
BGC0001438.1|Warkmycin_25 # 26773 # 27720 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.707	BGC0001438.1|Warkmycin_25 	26773	27720	-	Loose	600	25.7942	OprZ	40.0	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGCACCCGGTGCGCACGAGGTAGAGCACGACATCACGGTCTCGGCTCCCGCCTCCGCCGTCTACCGGCTGATCGCCGAGGTGGAGAACTGGCCCCGGATCTTCCCTCCGACCATCCACGTCGACCGGGTGGAGCACGACGGCGCCCGGGAGCGCATCCGCATCTGGGCCACCGCCAACGGTGAGGCCAAGCACTGGACCTCGCGCCGCACCCTGGACCCCGAGGGGCTGCGGATCGACTTCCGCCAGGAGGTCTCCACCCCTCCGGTGGCGGCCATGGGCGGAGCCTGGGTGGTGGAGCCGCTCGGACCCGACCGGTCGCGGGTCCGGCTGCTGCACGACTACCGGGCGGTCGACGACGATCCGGCGGGGCTGCGCTGGATCGAGGAGGCGGTGGACCGCAACTCCCGTTCGGAGCTCGCGGCCCTCAAGGACAACGTCGAGAACGCGCACGCCGCCGAGGCGTGGACCTTCTCCTTCTCCGACACCGTCCGGGCCACCGGGTCCGCCGAGGACATGTACGACTTCATCGACGAGGCCCAGCTCTGGCACGAGCGGCTCCCGCACGTCGCCTCGGTCCAGCTGTCGCAACAGCCCTCCGGACTCCAGGTGTTGAAGATGGAGACCCGGGCCAAGGACGGCTCGACGCATCTGACCGAGTCCTACCGGGTCTGCCTGCCCTCCGAACGGATCGCCTACAAGCAGACCACCCTGCCGGCGCTGATGTCGCTGCACACCGGGCTGTGGACCTTCGAACAGGACGGCCCCGAGGTCGTGGCGACGTCCCAGCACACCGTCGTGCTCCGTACGGAGAACATCACCGCCGTGCTCGGACCCGACGCGGGCGTGGAGGAGGCGCGTGAGTACGTACGCTCCGCGCTGAGCACCAACAGCCGCGCCACGCTCGGCCACGCGAGCGACTACGCCCGGGCGCAGCGGCGCTGA	MPAPGAHEVEHDITVSAPASAVYRLIAEVENWPRIFPPTIHVDRVEHDGARERIRIWATANGEAKHWTSRRTLDPEGLRIDFRQEVSTPPVAAMGGAWVVEPLGPDRSRVRLLHDYRAVDDDPAGLRWIEEAVDRNSRSELAALKDNVENAHAAEAWTFSFSDTVRATGSAEDMYDFIDEAQLWHERLPHVASVQLSQQPSGLQVLKMETRAKDGSTHLTESYRVCLPSERIAYKQTTLPALMSLHTGLWTFEQDGPEVVATSQHTVVLRTENITAVLGPDAGVEEAREYVRSALSTNSRATLGHASDYARAQRR	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	68.03	gnl|BL_ORD_ID|2408|hsp_num:0	2796			135	249	erythromycin; cefepime
BGC0001438.1|Warkmycin_26 # 27761 # 28543 # -1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.718	BGC0001438.1|Warkmycin_26 	27761	28543	-	Loose	750	31.9574	mdtH	28.24	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCGGATCAGCAGCGCGTCGCGCTCGTCACCGGCGGCACCAGCGGTATCGGACTGGCCGTCGCCCGGCTCCTGGGCGCCCAGAGCCACGCCGTCTTCATCGGGGCCCGCAGCGCCGACAACATCGCCTCGACCGTCAAGGAGCTGCGCGCCGAGGGCCTGGAGGCCGACGGCCTGGCCTGCGACGTCCGCTCCGGCCCCGAGGTCGCGGCCTTCGTCGCGGCGGCGGTGGACCGGTACGGCACGATCGACGTCCTGGTCAACAACGCGGGCCGCAGCGGCGGCGGAGTCACCGCCGACATCGCCGACGAGCTGTGGGACGACGTCATCGCCACCAACCTCACGAGCGTCTTCACGGTGACCCGTGAGGTGCTGCGGGCCGGAGGCATGCGCGAGAAGAGCCGGGGCCGGATCATCAACATCGCCTCCACGGCCGGCAAGCAGGGTGTGGTGCTCGGCGCCCCGTACTCCGCCTCCAAACACGGTGTCGTCGGGTTCACCAAGGCCCTGGGCAACGAGCTCGCCCCCACCGGGATCACCGTCAACGCCGTCTGCCCGGGCTATGTCGAGACGCCCATGGCGCAGCGCGTACGGCAGGGCTACGCGGCCGCGTACGAGACCACGGAGGAGGCGGTGGGGGCGAAGTTCCGCGCCAAGATCCCCCTGGGGCGCTACTCCACCCCCGAGGAAGTGGCCGGACTGGTGGGCTATCTGGCCTCCGACACCGCCGCCTCGCTCACCTCGCAGGCCCTCAACGTCTGCGGCGGCCTGGGCAACTTCTGA	MPDQQRVALVTGGTSGIGLAVARLLGAQSHAVFIGARSADNIASTVKELRAEGLEADGLACDVRSGPEVAAFVAAAVDRYGTIDVLVNNAGRSGGGVTADIADELWDDVIATNLTSVFTVTREVLRAGGMREKSRGRIINIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQRVRQGYAAAYETTEEAVGAKFRAKIPLGRYSTPEEVAGLVGYLASDTAASLTSQALNVCGGLGNF	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	64.68	gnl|BL_ORD_ID|342|hsp_num:0	375			201	456	enoxacin; norfloxacin
BGC0001438.1|Warkmycin_27 # 28612 # 28875 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GAGA;rbs_spacer=3bp;gc_cont=0.686	BGC0001438.1|Warkmycin_27 	28612	28875	-	Loose	50	25.7942	vanW gene in vanB cluster	41.38	3002964	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGACCCAGCGGAATTTCACCTTCGACGACCTCAGGACCATTCTGCGCGAGGCGGCGGGCCTGGAGGACGAGGTCCTGGGCGACGACGCCCTGGACGCCGCGTTCGAGGACCTGGGGCTCGAATCGCTGGCCCTGCTGGAGACCGGCAGCCGGATCGAGCGGGAGTACGGAATCACCCTCGACGACAGCTCCCTCACCGGCTCGAAGACCCCTCGCGCCCTGCTGGAGATCGTCAACGGAGAGCTGGCGACGGCCGCCGCCTGA	MTQRNFTFDDLRTILREAAGLEDEVLGDDALDAAFEDLGLESLALLETGSRIEREYGITLDDSSLTGSKTPRALLEIVNGELATAAA	MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLTTMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKVRNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ	31.64	gnl|BL_ORD_ID|4678|hsp_num:0	1036			573	660	vancomycin
BGC0001438.1|Warkmycin_28 # 28872 # 30101 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.739	BGC0001438.1|Warkmycin_28 	28872	30101	-	Loose	500	30.8018	CPS-1	40.48	3003716	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CPS beta-lactamase	ATGAGCGGGACCGTCGTGGTCTCCGGCCTGAGCGTGGCCTCGCCCAACGGCCTCGGCACATCGGACTACTGGTCGGCCACCACCGCCGGCCGCAGCGGCATCGGACCCGTCAGCCGCTTCGACGCCTCGTCCTACCCCGCCGGACTCGCGGGCGAGGTCCCCGGGTTCGTCGCCGAGGACCATCTGCCGGGCCGGCTGCTGCCGCAGACCGACCGGATGACACGGCTGGCCCTGGTCGTCGCGGACTGGGCGCTGGCCGACGCGGGCGTGCGGACCGAGGAGACCCCCGCCTACGACATGGGGGTCGCCACCGCCAGTTCCTCCGGCGGCTTCGAGTTCGGACAGAACGAACTGCGGGCGCTGTGGAGCAAGGGCAGCCAGTACGTCAGCGCCTACCAGTCGTTCGCCTGGTTCTACGCGGTCAACACCGGCCAGATCTCGATCCGCAACGGGATGAAGGGGCCCGGGAGCGTGGTCGTCAGCGATCAGGCGGGTGGCCTGGACGCGGTCGCCCAGGCGCGCCGGCAGGTCCGCAAGGGCATCCCCATGGTCCTCACCGGGGGGATCGACGCCTCGCTCTGCCCCTGGGGCTGGGTCGCGCAGATGTCCGCCGGGCGGCTCAGCACCACCCGTGACCCCGCGCGCGCCTACCTCCCCTTCGACGCCGCGGCCGACGGACACGTACCCGGCGAGGGCGGGGCGCTCCTCGTCGTCGAGGACGAGGAGGCGGCGCACCGGCGCGGCGCCCGCAGCCTCGGCGAGATCGCCGGCTACGGGTCCACGTTCGACCCGGCCCCCGACAGCGGACGGCCGCCGACCCTGCGCACCGCGATCGAGATCGCCCTGCGGGACGCGGGCATCACCGCCGACGACGTGGACGCCGTCTTCGCCGACGGCGCGGGACTGCCGGACCTGGACCGGGCGGAGGCCCTGGCGCTGACCGAGGTGTTCGGCGCCGGGGGCGTTCCTGTGACCGTCCCCAAGACGATGACCGGACGGCTGCACTCCGGAGCGGCACCGCTCGATCTGGCCGGTGCCCTGCTCGCCATGAGGGACGGCGTGATCCCGCCCACCGTCAACGTGTCGCCGAGCCCCGGCCTCGCCCTCGACCTGGTCTGCGAGACGCGCCCCGCGCGGCTCGGGACCGTGCTCGTCCTGGCCCGCGGCCATCACGGATTCAACTCCGCGATGGTGCTGCGCGCCCCCCGAACCCGACAAGGAGACCGATGA	MSGTVVVSGLSVASPNGLGTSDYWSATTAGRSGIGPVSRFDASSYPAGLAGEVPGFVAEDHLPGRLLPQTDRMTRLALVVADWALADAGVRTEETPAYDMGVATASSSGGFEFGQNELRALWSKGSQYVSAYQSFAWFYAVNTGQISIRNGMKGPGSVVVSDQAGGLDAVAQARRQVRKGIPMVLTGGIDASLCPWGWVAQMSAGRLSTTRDPARAYLPFDAAADGHVPGEGGALLVVEDEEAAHRRGARSLGEIAGYGSTFDPAPDSGRPPTLRTAIEIALRDAGITADDVDAVFADGAGLPDLDRAEALALTEVFGAGGVPVTVPKTMTGRLHSGAAPLDLAGALLAMRDGVIPPTVNVSPSPGLALDLVCETRPARLGTVLVLARGHHGFNSAMVLRAPRTRQGDR	MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTDKGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYVDEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSCSFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVASHASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK	141.03	gnl|BL_ORD_ID|2028|hsp_num:0	2231			327	453	
BGC0001438.1|Warkmycin_29 # 30098 # 31402 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.719	BGC0001438.1|Warkmycin_29 	30098	31402	-	Loose	750	171.785	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.17	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCGTACGACCGGACCGCGCACACCCCGCCGCCGGCGGACGGCGGGTCGCCGTCACCGGTATCGGGGTGCTCGCCCCCGGCGGAGTCGGCACGAAGGCGTTCTGGGAACTGCTCACCGCCGGCCGCACCGCGACCCGCGCCGTCAGCACCTTCGACCCGACCCCCTTCCGCTCCCGCGTCGCCGCGGAGATCGACTTCGACGCCGAGGCGCTCGGCCTCGGCCCGCAGGAGATCCGGCGCATGGACCGCGCCGCGCAGTTCGCCGTGGTCGCCGCCCGGGAGGCGTTCGACGACAGCGGCCTGGACAAGGACCGGCTGCCCCGGCACCGTACCGGCGTCGCCATCGGCAGCGCCGTGGGCGCCACCATGAGCCTCGACGAGGAGTACCGGGTGCTCAGCGACCGGGGCCGGCTGGAACTGGTCAGCCACACCTACGCGCCCCGCTTCCTGTACGACGCCTTCGTCCCCAGCTCGTTCGCCGCCGAAGTGGCCTGGACGGTCGGGGCGGAAGGCCCCACCACGGTGATATCCACCGGGTGCACCTCGGGCATCGACTCCGTCGGGTACGCCACCGAACTGATCCGGGAGGGCTCCGCGGACATCATGATCGCCGGTGCCACGGACGCCCCGATCTCCCCGATCACCCTCGCCTGCTTCGACGCGATCAAGGCGACGACCCCGCGCAACGAGGACCCCGCGCACGCCTCCCGCCCCTTCGACGCCACCCGCAACGGGTTCGTCCTGGGAGAGGGCAGCGCGGTCTTCGTCCTGGAGGAGCTGGGAAGCGCCCTCGACCGGGGCGCCCACGTCTACGCGGAGATCAGCGGCTACGCGACGCGCAGCAACGCCTACCACATGACCGGACTGCGGCCGGACGGCACGGAGATGGCCGAGGCCATCCGCGTCGCCCTCGACGAGGCCCGTACCGACCCCGCGGACATCGACTACATCAGCGCCCACGGATCCGGCACCCGGCAGAACGACCGGCACGAGACGGCAGCCTTCAAGAAGAGTCTCGGCGAGCACGCCCGGCAGGTGCCCATCAGCTCCATCAAGTCCATGGTGGGCCACTCGCTCGGCGCCATCGGCTCCATCGAGATCGCCGCCTGCGCGCTCGCCATGGAGCACGACGTCGTGCCGCCGACCGCCAACCTGCACCACCCCGACCCCGAATGCGACCTCGACTACGTCCCCCTGACCGCACGCGACTGGTCCACCGACTCCGTGCTCACCGTCGGCAGCGGATTCGGCGGGTTCCAGAGCGCCATGGTGCTGACCCGGCCGGAAGGAGGAACCGCATGA	MTVRPDRAHPAAGGRRVAVTGIGVLAPGGVGTKAFWELLTAGRTATRAVSTFDPTPFRSRVAAEIDFDAEALGLGPQEIRRMDRAAQFAVVAAREAFDDSGLDKDRLPRHRTGVAIGSAVGATMSLDEEYRVLSDRGRLELVSHTYAPRFLYDAFVPSSFAAEVAWTVGAEGPTTVISTGCTSGIDSVGYATELIREGSADIMIAGATDAPISPITLACFDAIKATTPRNEDPAHASRPFDATRNGFVLGEGSAVFVLEELGSALDRGAHVYAEISGYATRSNAYHMTGLRPDGTEMAEAIRVALDEARTDPADIDYISAHGSGTRQNDRHETAAFKKSLGEHARQVPISSIKSMVGHSLGAIGSIEIAACALAMEHDVVPPTANLHHPDPECDLDYVPLTARDWSTDSVLTVGSGFGGFQSAMVLTRPEGGTA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	104.33	gnl|BL_ORD_ID|1968|hsp_num:0	1943			213	1245	isoniazid
BGC0001438.1|Warkmycin_30 # 31399 # 31728 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.700	BGC0001438.1|Warkmycin_30 	31399	31728	-	Loose	700	25.409	oleI	33.33	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCACAGCACGTTGATCGTCGCCCGGATGGACCCCGCGTCGGCCGGTGACGTCGGCCGGCTCTTCCGGGACTTCGACACCACGGAGATGCCGCACCGGATGGGCACCCGCCGCCGGCAGCTCTTCTCCTACCAGGGGCTGTACTTCCACCTCCAGGACTTCGAAGCGGCCGACGGCGACCAGCGGATCGAGGAGGCGAAGACCGACCCGCGCTTCGAGCGGATCAGCGCCGACCTGCGGCCCTTCATCGACGCGTACGACCCCGAGACCTGGCGCTCCCCGGCCGACGCGATGGCCCGGCGCTTCTATTCCTGGCAGGCCTCCCGATGA	MHSTLIVARMDPASAGDVGRLFRDFDTTEMPHRMGTRRRQLFSYQGLYFHLQDFEAADGDQRIEEAKTDPRFERISADLRPFIDAYDPETWRSPADAMARRFYSWQASR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	25.71	gnl|BL_ORD_ID|1684|hsp_num:0	1824			240	387	oleandomycin
BGC0001438.1|Warkmycin_31 # 31777 # 33201 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728	BGC0001438.1|Warkmycin_31 	31777	33201	-	Loose	550	296.975	Nocardia farcinica rox	42.08	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCTGGCCGGTGAGCTGCGGCTCGGCGGCGTCGACGTCATGGTGCTCGAACAGCTTCCCCAACGCACCGGGGAGTCCCGCGGGCTGGGTTTCACCGCCCGGACCATGGAGGTCTTCGACCAGCGCGGAATTCTGCCCGCCTTCGGCCCCGTCGAGACAAGTACCCAGGGGCACTTCGGCGGCCGGCCGGTCGACTTCGGGGTACTCGAAGGAGCGCACTACGGCGTGAAAGCCGTTCCGCAGTCCAAGACCGAGTCGGTCCTGGAGGAGTGGGCGCTCGGACAGGGAGCGGAACTTCTGCGCGGCCACACGGTCCGGGCGCTCACGGACGAGGGCGACCACGTCGTCGTGGAGGTCGAGGGCCCCGACGGGCCCCGCAGCCTCACCGCCCGCTACGTCGTCGGCTGCGACGGCGGACGCAGCACCGTCCGCAAGGCGGCCGGGTTCGACTTCCCCGGCACCTCCGCCAACCGGGAGATGTTCCTCGCCGACATCCGCGGCTGCGAGATCACCCCTCGCCCCATCGGCGAGACGGTGCCGCTCGGAATGGTGATGTCCGCGCCGCTGGGCGACGGGGTCGACCGCATCATCGTCTGCGAGCGCGGCGCCCCCGCCCGCCGCCGCACCGGGCCGCCCCCGTACCAGGAGGTCGCCGCCGCGTGGCAGCGGCTCACCGGACAGGACATCTCGCACGGAGAGCCGGTCTGGGTCAGCGCCTTCGGGGATCCGGCCCGCCAGGTGTCCGCCTACCGGCGCGGCCGGGTGCTGCTCGCGGGCGACTCCGCGCACGTGCACCTCCCGGCGGGGGGCCAGGGAATGAACGTCAGCGTGCAGGACTCGGTGAACCTCGGCTGGAAGCTCGCGGCCGTGGTCGCGGGCCGCGCGCCGGCCGGACTCCTCGACACGTACCACGAGGAGCGCCACCCGGTGGGACGCAGGCTGCTGATGAACACGCAGGCCCAGGGGATGCTCTTCCTCAGCGGCGATGAGATGCAGCCGCTGCGGGACGTGCTGAGCGAACTGATCCGGTACGACGAGGTCTCCCGGCACCTGGCCGGCATGGTCTCCGGCCTGGACATCCGCTACGAGGTCGACGGCGGGGACCACCCGTTGCTCGGCATGCGCATGCCCCACCAGGAACTGGTCCGGGCCGACGGCAAGACCAGCACCACCGAACTGCTGCACCCGGCCCGGGGCGTGCTGCTCGACATCGCCGACGACGCGGACGTGCGCGAGGCCGCCGCCGGCTGGAGCGACCGGGTGGACCTCCACACCGCCTCCCTCCACGACGCCCCGCCGCAGGGCCCGTTGTCCGACGCCCGGGCCGTGCTGGTCAGGCCCGACGGATACGTGGCCTGGATCTCGCCCGGCAGCCGCGCCGGACTCACCGAGGCCCTGGACCGCTGGTTCGGTCCGGCCCGCTGA	MLAGELRLGGVDVMVLEQLPQRTGESRGLGFTARTMEVFDQRGILPAFGPVETSTQGHFGGRPVDFGVLEGAHYGVKAVPQSKTESVLEEWALGQGAELLRGHTVRALTDEGDHVVVEVEGPDGPRSLTARYVVGCDGGRSTVRKAAGFDFPGTSANREMFLADIRGCEITPRPIGETVPLGMVMSAPLGDGVDRIIVCERGAPARRRTGPPPYQEVAAAWQRLTGQDISHGEPVWVSAFGDPARQVSAYRRGRVLLAGDSAHVHLPAGGQGMNVSVQDSVNLGWKLAAVVAGRAPAGLLDTYHEERHPVGRRLLMNTQAQGMLFLSGDEMQPLRDVLSELIRYDEVSRHLAGMVSGLDIRYEVDGGDHPLLGMRMPHQELVRADGKTSTTELLHPARGVLLDIADDADVREAAAGWSDRVDLHTASLHDAPPQGPLSDARAVLVRPDGYVAWISPGSRAGLTEALDRWFGPAR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	100.21	gnl|BL_ORD_ID|4834|hsp_num:0	5821			42	1416	rifampin
BGC0001438.1|Warkmycin_32 # 33881 # 34681 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.770	BGC0001438.1|Warkmycin_32 	33881	34681	+	Loose	850	25.7942	OpmB	43.75	3004072	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGAGTACGCGGGGGACGGCCCCGCAGACGCTGTGCCGCGCGTGCGTGGATTCACTGAGGGCGACCCTGTGCGCCCTGCCCCAGCTGTACGGGGAATGCGGCCGGCTCCTCACCGGCGTCGCCTCTCCCCGGACGGAAAGGACGAGCGGGGGTGGCCGGGCCCCGGGAATTCCGCTCAACACCTCGGCCGTGGAGGCGCGTTCGGCCATCGTCACCACACTCGCGTCGTGGGCCGGCCTGGCGGCGGAGTCCGGTGGGCGGCCCGGTCCGGAACGGACGGTGCCGGCTCTGGCCCGCTGGCTCGGCGAGGAACTGCCCCGGATCGCCGTGCACCCGGCGGCGGGCGAGTTCTCGAAGGAGGTGCACCGGCTGGCGGCGGGGGCCCGCCGGGTGGTGTCGCCGGGGCCGGCGCACCGGGCCCCGGTCGGCACCTGCGTGGAGCCCGGCTGCGAAGGGAAGCTCGTGGCCACGACGGGGGCGGGTCCGGGCGGGCTGGGCGAGATCCGGTGCGACAGGGACGGGGCCCACTCCTGGACGGAGTACGACTGGAGCCGGCTGCGTCGGCGGCTGGCCGCCCGGAGCGCGGTCCTGGCGGGGGCCGCCGCGGGGGCCCCGGCGACCCGGTGGCTCGCGCCCCAGGACGTCTCCCTGCTGTGGCGCGTCCCCCTCGGCAGTGTGTACCGGCTCGCCAGCGAACAGAGCTGGCGGCGTGAGCGGCGCGGGGGGCGGTCCTACTACGACGAGCAGGACGTGCGGCGTACCCTCGACGCGCGCCTGACCGGGCCCGCACGCTCCTGA	MRSTRGTAPQTLCRACVDSLRATLCALPQLYGECGRLLTGVASPRTERTSGGGRAPGIPLNTSAVEARSAIVTTLASWAGLAAESGGRPGPERTVPALARWLGEELPRIAVHPAAGEFSKEVHRLAAGARRVVSPGPAHRAPVGTCVEPGCEGKLVATTGAGPGGLGEIRCDRDGAHSWTEYDWSRLRRRLAARSAVLAGAAAGAPATRWLAPQDVSLLWRVPLGSVYRLASEQSWRRERRGGRSYYDEQDVRRTLDARLTGPARS	MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP	53.41	gnl|BL_ORD_ID|2312|hsp_num:0	2716			444	540	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0001438.1|Warkmycin_33 # 34792 # 35586 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.610	BGC0001438.1|Warkmycin_33 	34792	35586	-	Loose	400	144.05	vanR gene in vanM cluster	35.02	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGATGGGGCGCGAATGGTTGCAGAAAGTAAGGACCGTGGGAATTGACTTCCCGATGGAGGGGGAACTGATTCCATCAGCCGCCGTCGTCCACCCCATGTGTTGGATAGAGAGGCGACCGATGCAGGTACTACTTGCCGAGTCCGACAAGCAATCGGGGGAGGATCTTCGCTTGGCCTTGCTGCGGCATGGGTACGAGATGGAAGTGGCTGACAGTGGTGCCAGCGCCCTGCGATCCTACGAAGAATTCGACCTCATTCTTCTGGATCTCGAACTGCCGGACATCGACGGCTTGGAAGTATGTCGAACGATAAGGCAGAGCAGTGACATCCCTATTATCTCCTTCACGGGGCAGGGTGCGGAAATCGACAGGGTGCTCTCTCTGCAGGCGGGAAGCGACGACTGCATTGTGAAGCCGTACGGTCTCCGTGAATTAATCGCCCGAATCAACGCGGTAATGCGCCGCGCGAGCCCGAGTGTCCGCCGTGATCGTGTGATGTCTTTCGGGACCTTGTGCATCGACGGCGAGGGGCGTCAGGTGTATCTGGACGACGAACCCGTGAAGCTGACCCGCAAGGAATTCGATCTGCTTCATCTGCTGGCGTCCCAGCCGGCCACGGTCTTCACCCGTGAGCAGTTGATGCGGCAGATCTGGGGGGTGAAGCCGGGCGGCGGGAGCCTCGCCGGCGGGCTCACCCGCACGATCGACACGCACGCCAGCTCGATCAGGGGGAAGCTCGGCTCCAGCGAGTGGATCATCACGGTGCGGGGCGTGGGGTTCCGCTTCGGCGGCTGA	MMGREWLQKVRTVGIDFPMEGELIPSAAVVHPMCWIERRPMQVLLAESDKQSGEDLRLALLRHGYEMEVADSGASALRSYEEFDLILLDLELPDIDGLEVCRTIRQSSDIPIISFTGQGAEIDRVLSLQAGSDDCIVKPYGLRELIARINAVMRRASPSVRRDRVMSFGTLCIDGEGRQVYLDDEPVKLTRKEFDLLHLLASQPATVFTREQLMRQIWGVKPGGGSLAGGLTRTIDTHASSIRGKLGSSEWIITVRGVGFRFGG	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	113.79	gnl|BL_ORD_ID|4735|hsp_num:0	752			3	696	vancomycin; teicoplanin
BGC0001438.1|Warkmycin_34 # 36123 # 36725 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGAGG;rbs_spacer=8bp;gc_cont=0.695	BGC0001438.1|Warkmycin_34 	36123	36725	-	Loose	700	25.7942	ADC-84	52.38	3006441	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGACAGACACCCCTTTGCGCCTGGTCGTTCTCATCGGCAGCCACCGGGAGGGCAGGTTCGCCCCGACGGTGGCCCGCTGGCTCCTCGCGCAGTTGGAGCAGCACGCCGACTTCGACGTGGAGGTCATCGACGCGGCGCAGGCGGGACTCAACGCGGAGGGCCCGTCGCCGACGGCCTCGCTCCCGGTGCTCGAAGCGGTCGGTGCTCTCGCCGAACGGATGGACGCCGCCGACGCGTTCGTCGTCGTGACGCCCGAGTACAACCACAGCTACCCCGCGTCCCTGAAGAGCCTGATCGACTGGCACCGCACCCAGTGGCAGGCCAAGCCCATCGGCTTCGTCTCGTACGGCGGGATGAGCGGGGGCCTGCGCGCGGTGGAGCATCTGCGACAGATCTTCGCCGAGCTGCACGCGGTCACCGTCCGTGACACCGTCAGTTTCCACCAGGCGTGGGAGCGGTTCGACGAGCAGGGCGAGGTCAGGGACACCGAGGGTCCCGCACTCGCGGCGAAGGCCATGCTGGATCAGCTCGCGTGGTGGGGGACGACACTGCGTACGGCCAGGGCCGAACGCCCCTACGTGGCGCAGTCGACGGGAGTGTAG	MTDTPLRLVVLIGSHREGRFAPTVARWLLAQLEQHADFDVEVIDAAQAGLNAEGPSPTASLPVLEAVGALAERMDAADAFVVVTPEYNHSYPASLKSLIDWHRTQWQAKPIGFVSYGGMSGGLRAVEHLRQIFAELHAVTVRDTVSFHQAWERFDEQGEVRDTEGPALAAKAMLDQLAWWGTTLRTARAERPYVAQSTGV	MRFKKISCLLLPSLFILNTSIYAGNTSKDQGIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNKGKISFEDTPSKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKIVGLSMNQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQSAINETHKGFYQVGTMYQALGWEEFSYPASLQTLLDSNSEQIVMKPNKVTAISNEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	52.22	gnl|BL_ORD_ID|3271|hsp_num:0	4340			894	957	
BGC0001438.1|Warkmycin_35 # 36722 # 38314 # -1 # ID=1_35;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0001438.1|Warkmycin_35 	36722	38314	-	Loose	900	212.231	otr(B)	35.35	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGCAGGACGAGGCGCCGCCCGCGTTAGCCGTGTCGAAACGGCAGCTCTACGCCGTCATCGCGGCAGCCCTGCTGGCCATGCTGCTGGGCGCTCTGGACGGCATGATCGTCGGCACCGCGATGCCGCAGATCGTGGGCGAACTCGGAGGCTTCGACCGGCTGTCCTGGGTGGTCACGGTCTATCTGCTGGCCATCGCCGTCACCACGCCCGTCTGGGGCAAGCTCGGCGACATGTACGGCCGCAAGGGCGCCTTCGCGATCTCGATCGTGGTGTTCGTCCTCGGCTCCGTACTGTCCGGCGCGGCCCAGGACATGACCCAGCTCATCATCTTCCGGGCCCTGCAGGGGCTGGGCGCGGGCGGACTGATGGTGGGGGCGCTGGCACTGATCGGTACGCTCATCCCGCCCCGTGAGCAGGGCAAGTACCAGGGCGTCATGTCCGCGGTCATGGGCCTCGCGATGGTGAGCGGGCCGTTGGTCGGGGGCGTCATCACCGACCAGCTCGGCTGGCGCTGGTGCTTCTACGTCAACGTGCCGGTCGGCGCGCTCGCCCTGCTGCTGATCTCGGGACTGCGCCTTCCCCGGACGCCCAGGTCCGGAGCGCGGGTGGACTACCCGGGCGTGCTGCTGCTGGCCGTGGCCGTCTCCGCGCTGGTCCTGGTGACCACCTGGGGCGGCAGGGAACTCGCCTGGACCTCACCGGTGTTGCTGACCGTGGCGGCGTGCGGAGTCTTCGCCCTGCTGGCGCTGTTGGTGGTGGAGCGGCGGGCGGACGAGGCGGTGCTGCCCCTCGCGCTGTTCAGGACGGCCAACTTCTCCCTCATCACCCTGGTCGGGCTGCTCCTGGGCGCGGTGCTGACCAGCGCCGTCACCTTCCTGCCGATCCTGGGGCAGTCGTCCCAGGGCTCGTCGGCGACCGGGAGCGGGCTGCTGCTCCTGCCGATGTTCGGGGCCATGGTCCTCGTCGGTCTGTTCGCCGGACGCTTCATCACCGCGACCGGCAAGTACAAGATCGTCGTCCTGCTGGGCGGATTCTTCCTGGTGGCGGGTTCGTTCCTGCTGGTGCCGGTCGACCGCGACACCAGCCCCTACTTCTCCGGGGCCTGCATGGCGGCCCTCGGCATCGGCATGGGGCTGCTGACCCAGACGACGATCCTGATCTCCCTGCAGAGCGCGCCGATCGAGGATCTGGGCGCGGCTTCCGGCGCCGCGACGCTCGCCCGGACCCTCGGCGGTTCCATCGGCGTCGCCGTCAGCGGTGCGCTCTTCGCCGGGGCGGTCTCGCGGGTCCCGGCCCCGGACAGCGCCGCGCCGTCCCCCGAGGGGGCGGCCACCCTCGACCCCGCAGCGCTCGCGCAACTTCCCGCCGCGGTGCGGGAGTCGTATCAGAGCGCGGTGGCGCAGGGCGCCTCCCACGTCTTCGTCTTCACCGGAGTGCTCGCCGCCGTCGCGTTGGCGGCCGCTTTCTTCCTGCGGGAGGTGCCGCTGCGTTCCGCGGGCGCCCCGCAGGACTCCGGTGGGAGCGCGAGTACCGGGGCCGGCCACACCGGTCCCGCCGAGAGCAGGAATGGGAAGAGGAACCCCACATGA	MPQDEAPPALAVSKRQLYAVIAAALLAMLLGALDGMIVGTAMPQIVGELGGFDRLSWVVTVYLLAIAVTTPVWGKLGDMYGRKGAFAISIVVFVLGSVLSGAAQDMTQLIIFRALQGLGAGGLMVGALALIGTLIPPREQGKYQGVMSAVMGLAMVSGPLVGGVITDQLGWRWCFYVNVPVGALALLLISGLRLPRTPRSGARVDYPGVLLLAVAVSALVLVTTWGGRELAWTSPVLLTVAACGVFALLALLVVERRADEAVLPLALFRTANFSLITLVGLLLGAVLTSAVTFLPILGQSSQGSSATGSGLLLLPMFGAMVLVGLFAGRFITATGKYKIVVLLGGFFLVAGSFLLVPVDRDTSPYFSGACMAALGIGMGLLTQTTILISLQSAPIEDLGAASGAATLARTLGGSIGVAVSGALFAGAVSRVPAPDSAAPSPEGAATLDPAALAQLPAAVRESYQSAVAQGASHVFVFTGVLAAVALAAAFFLREVPLRSAGAPQDSGGSASTGAGHTGPAESRNGKRNPT	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	94.14	gnl|BL_ORD_ID|889|hsp_num:0	870			51	1671	tetracycline
